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INTRODUCTION 
The distinction between cavernous haemangiomas of the liver (which are the 
second most common hepatic mass lesions) from malignant lesions, is often 
difficult. An incorrect diagnosis of cavernous haemangioma, in a patient with 
malignancy, may adversely influence the outcome of subsequent treatment in 
these patients, due to delay in therapy. Although previous studies have 
suggested that 99mTc erythrocyte blood pool scintigraphy is both highly 
sensitive and specific for haemangiomas, a basic flaw in all previous studies 
has been the small number of control patients studied. Bayesian analysis 
clearly shows that specificity for a test is dependant on the pre-test probability 
of the lesion being present. Thus all the studies done to date, may reflect an 
inappropriately high specificity for 99mTc scintigraphy, in diagnosing cavernous 
haemangiomas, because they have mainly studied patients with 
haemangiomas and relatively few patients with other lesions. 
This study was thus undertaken to clarify the true accuracy of this technique, in 
distinguishing haemangiomas from other hepatic mass lesions, by studying a 




REVIEW OF THE LITERATURE 
HISTORY 
The first description of haemangiomas of the liver in the medical literature 
appeared in 1861. In his treatise on liver disease, Frerichs (1861) said that 
hepatic haemangiomas were described by Dupuytren, Cruveilhier and 
Meckel, but that Virchow and Rokitansky were the first to examine these 
lesions carefully. While a few authors considered the liver cavernous 
haemangioma to be rare (Peck, 1921; Mantle, 1903), others considered it to 
be common and probably the best known and most common of all new 
growths in the liver (Major and Black, 1918). The consensus of the early 
authors was that hepatic cavernous haemangiomas were usually 
asymptomatic and of negligible clinical importance (Frerichs, 1861; 
Schmieden, 1900; Mantle, 1903; Major and Black, 1918). Several autopsy 
reports appeared in the literature at the turn of the century, including a 
description by Major and Black (1918) of the largest haemangiomatous liver 
(18160 grams) reported up to that time. The major emphasis in the literature 
at the end of the 19th century and in the first half of the 20th century 
however, was on large symptomatic haemangiomas and their surgical 
excision (Pfannenstiel, 1898; Langer, 1901; Fillipini, 1901; Mantle, 1903; Von 
Generisich, 1908; M'Weeney, 1912; Rubin, 1918; Peck, 1921; Eckles, 1927; 
Shumacker and Baltimore, 1942; Wilson and Tyson, 1952; Henson et al., 
1956b). 
An annotated bibliography of the historically relevant papers is given in 
Appendix 1. 
AETIOLOGY AND PATHOGENESIS 
The primordial network of endothelium and blood spaces in the human 
embryo develops in the third week from the mesoderm overlying the yolk sac, 
at the junction of the foregut and the hindgut. It is here that the vascular tree 
2 
takes root with the major structures of heart, aorta and hepatic vessels first 
appearing, growth following by extension from this central mesenchymal 
network. Haemangiomas follow the central and peripheral growth zones of 
the vascular system in their distribution (Geschickter and Keasbey, 1935). 
Two major hypotheses of pathogenesis subsequently evolved: 
(i) One of a hamartomatous origin (Schmieden, 1900; Borst, 1911; Major 
and Black, 1918; Feldman, 1958; Kojima-hara, 1986; Craig et al., 1989; 
Watson and McCarthy, 1940); 
(ii) The other of an angiomatous origin (Moore, 1944; O'Donoghue and 
Nicosia, 1950; Boyd, 1970; Robbins, 197 4; Canter and Longmire, 1988). 
A hamartoma, by definition, is a mixture of tissue commonly present in an 
organ, but present in a disordered arrangement. In contrast, an angioma is a 
true benign neoplasm of blood (or lymph) vessels. An intermediate 
hypothesis, in which a hamartomatous origin is accepted but with additional 
growth by proliferation of endothelial structures rather than simple 
enlargement by ectasia alone, is assumed by others (Ribbert, 1898; Eckles, 
1927; Borst, 1911; Major and Black, 1918; Roggenbau, 191 O; Robbins, 
197 4). 
Hypotheses on the mechanism of growth or expansion of the cavernous 
haemangioma in the literature fall into two major schools. The hypothesis of 
ectasia postulates that expansion occurs initially with growth of the liver, 
followed by ectasia of pre-existing vascular channels without hyperplasia or 
hypertrophy (Trastek et al., 1983; Adson, 1986; Nichols et al., 1989). The 
hypothesis of new growth postulates the extension of newly-formed 
endothelial buds from intrinsic vascular structures into surrounding tissue, 
which is displaced by the constant formation of new vessels. Solid cords 
undergo canalization and establish communication with the parent vessel, but 
do not invade or communicate with surrounding normal vessels. (Ribbert 
1898, cited by Watson and McCarthy, 1940; O'Donoghue and Nicosia, 1950; 
Canter and Longmire, 1988). 
Coexistence of hepatic cavernous haemangioma and focal nodular 
hyperplasia has been observed by several workers and suggests that these 
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lesions are pathogenetically related (Benz and Baggenstoss, 1953; Mathieu 
et al., 1989; Ndimbie et al., 1990) and developmental in origin (Wanless and 
Mawdsley, 1985). See Appendix 14. 
The possible association between oral contraceptives and benign hepatic 
tumours was brought to light for the first time in 197 4 (Baum et al., 1973). 
Subsequently, reports have appeared in the literature of the diagnosis of 
focal nodular hyperplasia and liver cell adenoma (Nissen et al., 1976), liver 
hamartomas (O'Sullivan and Wilding, 1974; Nissen et al., 1976), and liver 
haemangiomas (Tait et al., 1992, Sinanan and Marchioro, 1989) in patients 
receiving oral contraceptive steroids (OCS) or exogenous oestrogen 
replacement therapy. These findings suggest a possible aetiological role of 
these hormones. The presence of moderate liver damage and hepatomegaly 
with periportal sinusoidal dilatation, demonstrated histologically in females on 
long term treatment with OCS, further suggest a role in the pathogenesis of 
vascular tumours of the liver (Winkler and Poulsen, 1975; Canter and 
Longmire, 1988). An aetiological role of OCS and anabolic steroids in the 
rare diffuse hepatic haemangiomatosis or peliosis hepatis has been 
suggested (Klatskin, 1977; Gordon et al., 1960; McGiven, 1970). 
Hepatic cavernous haemangiomas may increase in size and become 
symptomatic in response to exogenous oestrogens and OCS (Morley et al., 
1974; Tait et al., 1992), but this situation is also documented in the complete 
absence of endogenous and exogenous oestrogen stimulation (Du Pre and 
Fincher, 1992). It has been suggested that exogenous oestrogen withdrawal, 
and possibly oestrogen receptor blockade by specific antagonists, may slow 
growth of the lesion (Sinanan and Marchioro, 1989). Recurrence following 
ablative therapy has been associated with exogenous oestrogen therapy 
(Canter and Longmire, 1988). A higher frequency of HCH has been reported 
in multiparous women (Ninard, 1950; Abrams et al., 1950; Mcloughlin, 1971 ). 
HCH may become symptomatic and/or undergo rapid enlargement during 
pregnancy (Rubin, 1918; Nichols et al., 1989; White, 1983; Creasy et al., 
1985; Schwartz and Husser, 1987). The effect of pregnancy on the growth of 
HCH is considered to be inconsistent by some authors (Kato et al., 1975; 
Schwartz and Husser, 1987). Sewell and Weiss (1961) described 
spontaneous rupture of a HCH, an otherwise rare complication, occurring in a 
pregnancy. 
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While the exact role of exogenous/endogenous oestrogenic steroids in the 
aetiology and pathogenesis of hepatic cavernous haemangioma remains 
unclear, the bulk of evidence seems to support a stimulatory role in the 
enlargement of pre-existing haemangiomas and the appearance of symptoms 
(Conter and Longmire, 1988; Zafrani, 1989). It could be speculated that the 
well known association between oestrogen use, or pregnancy, and worsening 
of angiomas of the skin/gingiva, may also exist within the hepatic parenchyma 
(Conter and Longmire, 1988; Edmondson, 1958). 
The earliest hypotheses on the pathogenesis of HCH before 1900 are 
summarised in Appendices 2, 3, 4 and 5. An annotated bibliography of the 
aetiological role of OCS, exogenous oestrogens and pregnancy in HCH is 
given in Appendices 6 and 7. 
PATHOLOGY 
Gross pathology 
Macroscopically, the hepatic cavernous haemangioma characteristically 
appears red, blue or purple (Edmondson, 1958; Goodman, 1987; Geschickter 
and Keasbey, 1935; Berk and Priest, 1965; Major and Black, 1918; Henson et 
a/., 1956b; Ochsner and Halpert, 1958; Ishak and Rabin, 1975; Craig et al., 
1989; Robbins, 197 4; Frerichs, 1861; Edmondson, 1958; Aspray, 1945), but 
may be grey or whitish in appearance depending on the amount of fibrosis or 
calcification present (Harataki et al., 1992; Plachta, 1962). 
The HCH is circumscribed (Geschickter and Keasbey, 1935; Plachta, 1962; 
Mantle, 1903; Ishak and Rabin, 1975; Kew, 1990), and well demarcated from 
the surrounding liver tissue (Aspray, 1945; Harataki et al., 1992; Henson et 
al., 1956b; Berk and Priest, 1965). Although generally non-encapsulated 
(Ishak and Rabin, 1975; Mantle, 1903; Kew, 1990; Robins, 197 4; Aspray, 
1945), a fibrous capsule may be present and may be accompanied by 
compression of the surrounding liver parenchyma (Frerichs, 1861; Adam et 
al., 1970; Wakeley, 1925). The absence of a fibrous capsule in the majority of 
haemangiomas and the fact that most haemangiomas are small, suggests 
that formation of a capsule occurs by compression of adjacent parenchyma, 
especially in larger and/or expanding lesions. When a capsule is lacking, the 
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cavernous spaces abut directly on the liver parenchyma, forming a very soft 
tumour, while the presence of a fibrous capsule is probably required to render 
a haemangioma readily palpable per abdomen (Wakeley, 1925). Liver 
haemangiomas may be elevated, depressed or pedunculated, irregular or 
lobulated masses (Ochsner and Halpert, 1958; Shumacker and Baltimore, 
1942; Henson et al., 1956b; Major and Black, 1918; Adam et al., 1970; Berk 
and Priest, 1965; Aspray, 1945). The consistency is soft or spongy (Ochsner 
and Halpert, 1958; Edmondson, 1958; Henson et al., 1956b; Berk and Priest, 
1965; Robbins, 197 4; Geschickter and Keasbey, 1935) and the masses are 
compressible (Robbins, 197 4; Nichols et al., 1989; Shumacker and Baltimore 
1942), although they may be firm when large amounts of fibrous tissue or 
extensive calcification is present (Harataki et al., 1992; Henson et al., 1956b; 
Berk and Priest, 1965; Adam et al., 1970; Plachta, 1962). 
When sectioned, they partially collapse due to the escape of blood (Ishak 
and Rabin, 1975; Goodman, 1987; Robbins, 197 4; Edmondson, 1958), 
appear round, oval or angular with a honeycomb or sponge-like cut surface 
(Ochsner and Halpert, 1958; Adam et al., 1970; Ishak and Rabin, 1975; Craig 
et al., 1989; Mantle, 1903; Goodman, 1987; Major and Black, 1918; Frerichs, 
1861; Edmondson, 1958). There may be evidence of recent or old thrombosis 
(Ishak and Rabin, 1975; Craig et al., 1989; Goodman, 1987; Frerichs, 1861; 
Tait et al., 1992; Harataki et al., 1992), with regressive or involutional 
changes such as fibrosis, calcification or necrosis (Ishak and Rabin, 1975; 
Craig et al., 1989; Goodman, 1987; Harataki et al., 1992; Aspray, 1945; 
Plachta, 1962; Berry, 1985). 
Liver cavernous haemangiomas are usually solitary, but the prevalence of 
multiple liver haemangiomas varies between 7 and 44 % (mean 22%). The 
probable reason for the variability in the reported prevalence of multiple vs. 
solitary haemangiomas is the selection bias in the studies reporting the 
higher prevalences (Trastek et al., 1983; Tait et al., 1992; Schmieden, 1900). 
In the studies of Tait et al. (1992) and Trastek et al. (1983), clear selection 
bias was present in that retrospective analysis was performed only of patients 
with an established diagnosis of HCH. It is therefore likely that in these 
selected groups, more patients with multiple HCH were included than would 
be found in the general population or in an unselected autopsy series. In the 
study of Schmieden (1900), an unequivocal selection bias is present in that 
selected autopsy haemangioma specimens were examined to investigate 
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structure and genesis, and the frequency of multiple haemangiomas cannot 
be representative of that obtained in unselected autopsy series. The 9% 
prevalence of multiple HCH found in the two large unselected autopsy series 
of Ochsner and Halpert (1958) and Feldman (1958) and quoted by 
Edmondson ( 1958) and Craig et al. ( 1989), also based on large autopsy 
series, probably represents the true prevalence. While the study of Henson et 
al. (1956b) has no or at most only partial bias, the number of patients is 
small, and the 17 - 18 % prevalence of multiple HCH may be overestimated 
(See Appendix 8). Rarely, the is liver diffusely involved by great numbers of 
small haemangiomas (Edmondson, 1958; Wilson and Tyson, 1952). 
The size of haemangiomas ranges from a few millimetres to greater than 20 
cm in diameter. In unselected autopsy and clinical series the majority are less 
than 4 cm in size (Edmondson, 1958; Feldman, 1958; Goodman, 1987; 
Ochsner and Halpert, 1958; Henson et al., 1956b ). The large lesions found in 
several surgical series reflect a bias introduced by selection of patients with 
large and usually symptomatic HCH for resection, and therefore does not 
reflect the average size distribution in the general population (See 
Appendices 9 and 10). Lesions exceeding 4 cm in diameter have been 
defined as massive or giant cavernous haemangiomas by Adam et al. (1970), 
based on their finding that no symptomatic tumour was encountered which 
was less than this size. (See Appendix 10). 
Haemangiomas occur most frequently in the right lobe of the liver (Frerichs, 
1861; Edmondson, 1958; Nelson and Chezmar, 1990; Kato et al., 1975; 
Ochsner and Halpert, 1958; Trastek et al., 1983; Henson et al., 1956b; Adam 
et al., 1970; Schwartz and Husser 1987; Andersson and Bengmark, 1988; 
Alper et al., 1988; Wilson and Tyson, 1952; Shumacker and Baltimore, 1942; 
Peck, 1921 ), which is probably simply due to the volume difference between 
right and left lobes (See Appendix 11 ). 
It is frequently stated that haemangiomas are more frequently found in a sub-
capsular location than deep within the parenchyma (Frerich, 1861; Abrams et 
al., 1969; Geschickter and Keasbey, 1935; Feldman, 1958; Watson and 
McCarthy, 1940; Ochsner and Halpert, 1958). In the study of Tait et al. 
(1992), an inversion of this commonly quoted high subcapsular/parenchymal 
ratio was reported with a higher percentage of deeply situated asymptomatic 
HCH and a higher percentage of symptomatic HCH situated in a subcapsular 
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location. This suggests that symptomatic lesions are large and subcapsular, 
while asymptomatic lesions are mostly deep. Seen as a whole, however, the 
available data in the limited number of studies is inconclusive and further 
study is required in this area (See Appendix 12). A predilection for the under 
surface is reported by some authors (O'Donoghue and Nicosia, 1950; 
Feldman, 1958). 
Histopathology 
Liver cavernous haemangiomas are composed of blood filled spaces of 
variable size and shape which are lined by a single layer of flat endothelium 
and separated by septa of moderately cellular fibrous connective tissue 
(Craig et al., 1989; Edmondson, 1958; Robbins, 197 4; Major and Black, 1918; 
Mantle, 1903; Berk and Priest, 1965; Henson et al. 1956b; Ochsner and 
Halpert, 1958; Adam et al., 1970; Harataki et al., 1992; Goodman, 1987; 
O'Donoghue and Nicosia, 1950; Nichols et al., 1989; Geschickter and 
Keasbey, 1935; Ishak and Rabin, 1975; Frerichs, 1861; M'Weeney, 1912). 
The endothelial cells are without atypia or increased cellularity (Craig et al. 
1989; Aspray, 1945; M'Weeney, 1912), supporting the clinical finding that 
these lesions are benign. Occasional reports of haemangiomas containing 
large and pale endothelial cells with elongated nuclei and of multiple 
endothelial cell layers have appeared (O'Donoghue and Nicosia, 1950; Lewin 
et al., 1992). 
The septa separating the loculi vary greatly in thickness, but are usually thin 
and often incomplete, poorly cellular and may have a myxoid appearance 
(Craig et al., 1989; Edmondson, 1958; Frerichs, 1861; Ochsner and Halpert, 
1958; M'Weeney, 1912). The stromal trabeculae may contain lymphocytes, 
smooth muscle cells and lipid-laden phagocytes (Adam et al. 1970; Major and 
Black, 1918; Frerichs, 1861 ). Occasionally papillary in-foldings into the 
cavernous spaces are present (Craig et al., 1989; Mantle, 1903; Geschickter 
and Keasbey, 1935). Major arterial branches and small bile ducts may be 
present in larger septa (Craig et al., 1989; Edmondson, 1958). Some large 
portal tract arteries have branches that merge with the cavernous spaces, 
producing arteriovenous shunting (Craig et al., 1989). 
The large, variably sized and convoluted blood spaces of the haemangioma 
result in sluggish blood flow, which is reflected on red cell scintigraphy by the 
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characteristic progressively increasing activity within the lesion. 
Physiologically, both ingress and egress of blood are slow and variable, and 
thus considerable time is usually required before the non-radioactive blood 
within the haemangioma is replaced by new inflowing (radioactive) blood 
(Good et al., 1978; Wilcox and Joo, 1980; Front et al., 1983). The flow 
dynamics further underlie the typical appearance of HCH, where decreased 
activity is found in the lesion relative to the adjacent parenchyma on 
radionuclide angiography. Visualisation in the venous phase depends on the 
volume of contained radioactive blood at any one time, as well as the 
presence and extent of fibrosis, necrosis or haematoma (Front et al., 1984; 
Rabinowitz et al., 1984 ). 
Arteriovenous shunts, as described by Craig et al. (1989), where portal tract 
arteries have branches that merge with the cavernous spaces, may explain, 
at least in part, the early arterial activity seen in the atypical appearance HCH 
during radionuclide angiography, but do not explain the continued high 
activity retained in the lesion in the late arterial and early venous phases, 
over and above the characteristically heightened activity in the mid to late 
venous phases. An additional explanation for an atypical appearance may be 
the presence of large bore cavernous spaces with a lesser degree of 
convolution, allowing rapid ingress and egress of radioactive blood A 
reversing vascular pattern was described by Hardoff et al. (1989), whereby a 
small central portion of a haemangioma revealed increased arterial flow 
initially and reduced blood pool activity subsequently, while the periphery of 
the lesion revealed decreased arterial flow initially and increased blood pool 
activity subsequently. In explanation he proposed a double vascular 
arrangement, with the presence of separate larger diameter vessels of lesser 
tortuousity supplying the central portion, surrounded by tortuous cavernous 
spaces. This however, fails to explain persistence of increased activity within 
an entire lesion or part thereof, from perfusion to late blood pool phases. The 
correlation between the atypical "arterialized" appearance HCH and the 
blood supply requires further clinicopathologic investigation, particularly in 
view of the necessary distinction of this entity from malignant neoplasm. 
Although most cavernous haemangiomas are well circumscribed and 
demarcated from adjacent liver tissue ( Craig et al., 1989; Robbins, 197 4; 
Goodman, 1987; Ochsner and Halpert, 1958), the connective tissue at the 
periphery may penetrate into the adjacent hepatic parenchyma, with liver cell 
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cords or lobules situated between adjacent blood spaces (Frerichs, 1861; 
Ochsner and Halpert, 1958; Goodman, 1987; M'Weeney, 1912; Geschickter 
and Keasbey, 1935; Craig et al., 1989). The adjacent hepatic parenchyma is 
usually not distorted or compressed (Ochsner and Halpert, 1958; Kato et al., 
1975), although O'Donoghue and Nicosia (1950) found compression of 
adjacent liver parenchyma in their case report. 
Marked septa! fibrosis or hyalinisation and calcification may rarely occur 
(Harataki et al., 1992; Aspray, 1945; Plachta, 1962; Edmondson, 1958). The 
cavernous spaces may contain fresh or organising thrombi (Craig et al., 
1989; Goodman, 1987), which may form and lyse constantly (Goodman, 
1987), due to the sluggish blood flow, and sometimes may undergo 
calcification or ossification (Craig et al., 1989; Edmondson, 1958). 
Blood supply 
The origin of the blood supply to the cavernous haemangioma is variable and 
controversial. Using dye injection techniques, Frerichs (1861) showed that 
the haemangioma was supplied by the smaller branches of the portal vein, 
while the hepatic artery supplied only the trabecular vessels and the vasa 
vasorum of the adjoining hepatic veins, without supplying blood to the 
cavernous spaces per se (Frerichs, 1861 ). M'Weeney (1912) demonstrated 
microscopic pouching and evaginations of the medium sized hepatic veins 
and suggested that these were the vessels supplying the cavernous 
haemangioma. However, although Frerichs, (1861 ), Ribbert (1898) and 
Mantle (1903) demonstrated the presence of large hepatic venous channels 
in the neighbourhood of hepatic cavernous haemangioma, they were all 
unable to demonstrate any communication with the surrounding blood 
vessels. 
Despite the controversy regarding blood supply, as already proposed by 
Frerichs in 1861, it is now generally accepted that the cavernous spaces of 
the haemangioma are supplied with blood from radicles of the portal vein. 
The hepatic artery may provide the vasa vasorum and septae with a nutrient 
blood supply, but normally do not supply the cavernous spaces with blood. 
The exception to this rule is the presence of arteriovenous shunting produced 
by branches of some large portal tract arteries that merge with the cavernous 
spaces (Craig et al., 1989). Thus, while the presence of such arteriovenous 
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shunts may produce increased perfusion in a haemangioma or part thereof, 
in effect these lesions are without arterialization as opposed to hepatocellular 
carcinoma, which is principally if not exclusively supplied via branches of the 
hepatic artery (the portal component is virtually absent). While the 
haemangioma is thus perfused via the portal vein system, they typically 
reveal hypoperfusion or at most slow perfusion in radionuclide angiography, 
owing to the sluggish inflow of blood into and circulation through the tortuous 
cavernous spaces, requiring gradual replacement of the large volume of non-
radioactive blood contained within the lesion with labelled blood (Good et al., 
1978; Wilcox and Joo, 1980; Front et al., 1983). Visualisation of the entire 
extent of the lesion by scintigraphy in the venous phase, requires complete 
mixing of the labelled erythrocytes with the non-labelled blood contained 
within the haemangioma. Characteristically, owing to an equally sluggish 
outflow of labelled blood from the tortuous cavernous spaces, the 
haemangioma reveals retention of labelled erythrocytes relative to adjacent 
parenchyma in the late venous phase (1-2 hours post injection). In contrast, 
hepatocellular carcinoma and metastases usually do not retain the labelled 
erythrocytes and characteristically become isoactive or hypoactive relative to 
adjacent parenchyma in the late venous phase. This forms the basis for the 
distinction between these lesions and the cavernous haemangioma on 
labelled erythrocyte blood pool scintigraphy. 
In addition to arteriovenous shunting, further variations in blood supply 
include arterio-portal shunting, usually a finding associated with 
angiosarcoma (Ando et al., 1984; Schima et al., 1989) and multiple small 
porto-hepatic venous shunts (Matsumoto et al., 1990). 
Morphological variants 
While fibrosis and calcification may be present in cavernous haemangioma 
(Edmondson, 1958), total sclerosis, hyalinisation or calcification is rare, 
(Harataki et al., 1992; Aspray, 1945; Plachta, 1962). Fibrous nodules with 
necrotic centres and identifiable vascular structures within the fibrous stroma, 
are considered to represent sclerosing haemangiomas (Berry, 1985; 
Shepherd and Lee, 1983). Pedunculation may be found in up to 33% of 
cases (Shumacker and Baltimore, 1942). Necrosis in hepatic cavernous 
haemangioma may result from involution and the lesion may mimic metastatic 
tumour (Berry, 1985; Shepherd and Lee, 1983). Infarction was suggested by 
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Bornman et al. (1987) to be the probable cause of the hitherto undescribed 
clinical triad of rigors, pyrexia and right upper quadrant tenderness, with or 
without hepatomegaly, in these patients. Diffuse systemic haemangiomatosis 
is a rare disease in adults, with multiple small haemangiomas in multiple 
organs, including bone, lung and liver (Kane and Newman, 1973; Sugimura 
et al., 1986). Haemangiomas of the liver may be associated with 
haemangiomas in other organs. See Appendix 13. 
Malignancy 
A single case of angiosarcoma associated with hepatic cavernous 
haemangioma has been described (Drouot et al., 1990), which may merely 
represent a chance association with a common tumour. 
Differential diagnosis 
Haemorrhagic vascular lesions which may mimic haemangiomas 
histologically include metastatic Kaposi's sarcoma, angiosarcoma, peliosis 
(angiomatosis) hepatis and possibly hereditary haemorrhagic telangiectasia 
(Edmondson, 1958; Craig et al., 1989). Angiosarcoma is characterised by 
the presence of atypical hypertrophic pleomorphic stratified lining cells with 
large elongated or angulated hyperchromatic nuclei, which is a hallmark of 
this tumour (Craig et al., 1989; Edmondson, 1958). Kaposi's sarcoma may 
appear bland histologically, composed of spindle cells and a few vascular 
spaces, involving portal areas ( Craig et al., 1989). Infantile 
haemangioendothelioma (a rare finding in adults with 90% being 
discovered in the first 6 months of life), usually is not as haemorrhagic as 
cavernous haemangioma and has more solid fibrous nodules (Craig et al., 
1989). Malignant epithelioid haemangioendothelioma consists of densely 
fibrotic nodules containing scattered elongated cells with vacuolated 
cytoplasm; at the periphery of the sclerotic mass, plump pleomorphic 
epithelioid cells with abundant densely eosinophilic cytoplasm and large 
mitotic nuclei extend into adjacent sinusoids (Craig et al., 1989). Peliosis 
hepatis is characterised by the presence of multiple small (< 5-10 mm 
diameter) dilated, blood filled cavities, not necessarily lined by endothelium, 
with liver cords and sinusoidal walls ending abruptly at the margins of the 
cavities; a supporting stroma is lacking, which aids histological distinction 
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from haemangioma (Craig et al., 1989; Edmondson, 1958). Hereditary 
haemorrhagic telangiectasia (Osler Weber Rendu disease) is rarely 
associated with liver involvement, but when present, exists as diffuse liver 
involvement with dilated (portal) vascular channels that lack the supporting 
stroma found in cavernous haemangioma (Craig et al. 1989). 
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Pathology of hepatocel/ular carcinoma and hepatocel/ular adenoma 
The gross pathology and histopathology of primary hepatocellular carcinoma 
and hepatocellular adenoma (Craig et al., 1989; MacSween 1980; 
Edmondson and Peters, 1977) are included in the pathological differential 
diagnosis of hepatic cavernous haemangioma, as these lesions frequently 
form part of the clinical and scintigraphic differential diagnosis. 
Hepatocellular carcinoma is a malignant tumour derived from the 
hepatocyte and occupies a unique position among neoplasms because of it's 
propensity to arise in an organ that is already damaged by another disease -
cirrhosis (Edmondson and Steiner, 1954). More rarely, primary hepatocellular 
carcinoma may arise in a non-cirrhotic liver. 
Primary hepatocellular carcinoma may be massive, nodular or diffuse. The 
right lobe is more frequently involved in both the massive and the nodular 
forms. In the massive type, the right lobe particularly may be largely replaced 
by a well-circumscribed, soft yellow-brown tumour. This type is more common 
in non-cirrhotic livers. Small secondary nodules are sometimes present in 
other parts of the liver. In the nodular type, there is usually one mass which is 
larger, appears older, is more circumscribed than any other lesion, and can 
be regarded as the primary lesion. Usually, nodules of smaller size are 
present throughout the remainder of the liver. Invasion of branches of the 
portal vein is probably responsible for the rapid spread to other parts of the 
liver. The nodular type may arise in multicentric foci (Fraumeni et al., 1968). 
The nodules often bulge beneath Glisson's capsule, are much softer to 
palpation than are areas of nodular regeneration and are rarely umbilicated. 
The presence of haemorrhage, necrosis and bile staining may produce wide 
variation in the coloration of the nodules, while considerable variation in 
consistency, size and growth pattern is also possible. Most commonly, 
hepatocellular carcinoma is golden yellow in colour, but may present a 
mixture of colours including green, pink, pearl-grey, red and black. The 
golden areas occasionally contain fat. The green colour is due to bile 
retention and haemorrhagic areas impart a red colour. The consistency of the 
tumour reflects the microscopic growth pattern. A soft smooth texture 
indicates a solid growth pattern with little or no trabecular formation. A tumour 
with a dry granular and friable cut surface usually has well defined trabecular 
pattern. A haemorrhagic tumour often reflects blood flow through widened 
trabeculae. White or grey coloration reveals the extent of collagenation, duct-
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like transformation and a lesser pooling of blood within the trabecular 
structures. 
Invasion of branches of the portal vein may result in the presence of solid 
tumour masses in the portal trunk and portal hypertension. Less often, the 
hepatic veins are invaded and a tumour thrombus may extend into the inferior 
vena cava, by which route the carcinoma may metastasize to the lungs and 
more distant structures. 
The microscopic appearance of hepatocellular carcinoma is highly variable 
between different tumours and even within the same tumour. Several 
biological factors contribute to the histological pattern. The relationship of the 
tumour to non-tumour parenchyma is reflected by the formation of nodules 
that extend or bulge into and enlarge within non-tumour liver parenchyma. A 
fibrous capsule is sometimes present. Tumour spread into the hepatic 
sinusoids has been reported by Nakashima et al. (1993). This occurred only 
in some poorly differentiated hepatocellular carcinomas, however. Sinusoidal 
tumour spread is more commonly seen in metastatic carcinoma than in 
hepatocellular carcinoma in the experience of Craig et al. (1989), while 
spread of hepatocellular carcinoma into the portal and hepatic veins is 
relatively common, especially in the cirrhotic liver. 
The tumour cells simulate normal liver cells, being characterised by large, 
round hyperchromatic nuclei, prominent nucleoli, and abundant eosinophilic 
cytoplasm. The relationship of the tumour cells to each other is reflected by 
their cohesiveness and a tendency toward arrangement in trabeculae that are 
usually two to eight cells in width. A microtrabecular pattern is present when 
the cell plates are less than 8 cells in thickness, whereas a macrotrabecular 
pattern is thicker. Necrosis occurring in some macrotrabecullae forms a 
gland-like space that mimics metastatic adenocarcinoma. An acinar or 
pseudoglandular pattern is present when a small lumen (canaliculus) is 
present, which often contains bile. Another feature indicative of origin from 
hepatocytes is the coverage of the trabecullae by a thin basement membrane 
envelope (as are the liver cords), with endothelial cells external to this. This 
arrangement is particularly noticeable when the tumour grows into blood 
vessels. The space surrounding the trabecullae is analogous to the 
sinusoidal spaces and carries arterial blood, and the vascular supply is 
abundant in most tumours. In the massive carcinomas, the trabecular pattern 
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is less obvious. Some hepatocellular carcinomas grow in solid sheets with 
few vascular channels and resemble squamous carcinoma. This pattern is 
called compact or solid type. Regardless of variations in pattern, most 
hepatocellular carcinomas are composed only of malignant cells and a 
capillary stroma. While stromal components of most hepatocellular 
carcinomas are minimal, and the excessive connective tissue characterising 
most adenocarcinimas is absent, some tumours incite a strong stromal 
reaction in the vascular component. The collagen formation results in a 
tubular or acinar pattern which may become glandular in appearance. 
Glandular transformation may thus develop in some trabecullar areas, while a 
small number of hepatocellular carcinomas have a marked glandular 
dilatation that resembles a thyroid acinus (adenoid pattern). Acini may or may 
not contain bile. Rarely, a papillary pattern is present as one of several 
patterns. The variation of histological patterns may result in misdiagnosis of 
metastatic carcinoma, on a small sample. Various degrees of sclerosis occur 
and if abundant in numerous sections, the term sclerosing hepatocellular 
carcinoma is applied, although this pattern accounts for less than 2 % of all 
hepatocellular carcinomas. A few carcinomas of hepatocyte origin are highly 
undifferentiated, forming spindle and giant cell types. In some carcinomas 
complicating cirrhosis, there is a combination of hepatocyte and bile duct 
carcinoma, with the former predominating as a rule. 
In the grading of hepatocellular carcinoma, criteria include degree of 
cytoplasmic acidophilia, nuclear chromatism, nuclear/cytoplasmic ratio, cell 
cohesiveness, cell function (bile production) and histological architecture. 
Grade I hepatocellular carcinoma: the nuclear/cytoplasmic ratio is nearly 
normal and this grade is recognised by the presence of a bulging nodule 
formation and compression of adjacent liver cords. In the presence of 
metastasis and/or vein invasion or the presence of other areas of grade II 
hepatocellular carcinoma, grade I hepatocellular carcinoma is clearly 
distinguished from hepatocellular adenoma. 
Grade II hepatocellular carcinoma has larger hyperchromatic nuclei, more 
eosinophilic cytoplasm and acini. In addition, formulation of trabecullae 
and papillae may be present. 
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Grade Ill hepatocellular carcinoma has yet larger hyperchromatic and 
more variable nuclei, with multiple nucleoli and comparatively less 
cytoplasm. There may be loss of trabecullar arrangement and syncytial 
giant cells are more numerous. Bile plugs are less evident. 
Grade IV hepatocellular carcinoma has less mature cells with large nuclei 
and little cytoplasm. This tumour grade may be hard to recognise as 
hepatocellular in origin. Trabecullae are rare and intravenous invasion by 
solid tumour may be found. Bile plugs are also rare. 
Many hepatocellular carcinomas have more than one grade of tumour, often 
separated by thin fibrous septae. 
Many of the functions of normal hepatocytes are retained in the malignant 
cells, such as the ability to secrete bile and to store glycogen. Cytoplasmic 
inclusions in hepatocellular carcinoma include Mallory bodies or alcoholic 
hyaline (Keely et al., 1972), pale bodies, a-1 antitrypsin bodies, and hyaline. 
Nuclear inclusions may be cytoplasmic invaginations. Fatty change may 
occur within the tumour cell cytoplasm, even though the non-tumour liver 
shows no significant fatty change. Calcification in hepatocellular carcinoma 
may occur due to tumour necrosis and degeneration. Although dystrophic 
calcification is rare, it may be extensive and may be detected by radiographic 
examination (Moenander, 197 4; Chin et al., 1986). An unusual case of 
ossification of a hepatocellular carcinoma was reported by Maeda et al. 
(1986). 
Electron microscopy may be useful in distinguishing hepatocellular carcinoma 
from metastatic carcinoma and cholangiocarcinoma. Although the 
ultrastructural features of hepatocellular carcinoma are variable, the 
cytoplasmic organelles resemble those of normal hepatocytes, while atypical 
inclusions are present. The histological grade is usually related to the amount 
and type of cytoplasmic organelles. Well differentiated hepatocellular 
carcinomas have feature of normal hepatocytes, whereas moderately 
differentiated hepatocellular carcinomas have nuclear invagination and loss 
of cytoplasmic organization, with variable numbers of mitochondria that often 
contain mitochondrial inclusions. The rough endoplasmic reticulum may be 
increased or distended and the smooth endoplasmic reticulum often forms a 
whorled pattern called ,,fingerprinting" or ,,myelin" figures (Ordonez and 
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Mackay, 1983; Schaff et al., 1971 ). Electron dense bodies may be numerous 
and appear to correspond to a-1 antitrypsin (by immunohistochemical 
staining). Bile canaliculi are present, but are diminished in number. 
Hepatocellular adenoma is a circumscribed, often but not always 
encapsulated, grey-brown bulging tumour composed of hepatocytes arranged 
in cords, and occasionally forms bile. The tumour is devoid of portal tracts 
and terminal hepatic veins. The tumours are usually very vascular and 
necrosis and haemorrhage are frequently present in larger tumours, which 
may undergo rupture. Although usually solitary, hepatocellular adenoma may 
be multiple. 
The oestrogen-associated hepatocellular adenomas are usually detected in 
young women with more than 5 years of oestrogen intake (Edmondson et al., 
1976). The tumours are usually somewhat lighter in colour than the 
surrounding liver. Glisson's capsule is usually smooth and glistening in those 
tumours which have not ruptured, although irregular bulging is usually 
present. A variegated, irregular, bulging cut surface of tan-coloured tissue is 
noted in those tumours without degenerative change or rupture. The bulging 
configuration is not the result of septae, but solid hepatocellular growth. 
Some hepatocellular adenomas have a homogeneous texture which is pitted 
by numerous tiny blood vessels and, rarely, fibrous septae. Resected 
hepatocellular adenomas often show variation in colour due to haemorrhage 
or infarction. The hepatocellular component is a lighter tan colour than the 
surrounding hepatic parenchyma. Varying degrees of infarction and 
haemorrhage may be present, particularly in the central portions. Infarction 
may be present with little or no haemorrhage. Ruptured tumours have 
abundant haemorrhage, recognised by bright to dark red clots, while old 
haemorrhage imparts a dark brown coloration. Degenerative changes, 
consisting of gelatinous areas or brown-grey connective tissue and 
pseudocyst formation, are common in larger tumours. 
The hepatocytes within the hepatocellular adenoma bear a close 
resemblance to those of the adjacent non-neoplastic parenchyma. The 
neoplastic hepatocytes grow in a discernible cord pattern, forming regular 
trabeculae two to three cells thick. Bile canaliculi are present and appear 
normal, although bile ducts are absent and there is no evidence of portal 
triads. In many tumours, however, the cords are closely approximated, 
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resulting in a sheet-like pattern. Hepatocellular adenomas are composed of 
four distinct types of neoplastic hepatocytes, that are referred to as 
neohepatocytes because of their similarity to normal hepatocytes, the 
absence of malignant cytological features, and their presence only within the 
hepatocellular adenoma and not within the adjacent normal hepatic 
parenchyma. The common neohepatocyte, occurring in one-third of 
hepatocellular adenomas associated with oestrogen intake, resembles a 
normal hepatocyte (except for it's presence within a hepatocellular adenoma) 
and has acidophilic cytoplasm. A second type of neohepatocyte is 'hydropic' 
and the cellular organelles appear to be concentrated around tiny canaliculi. 
This hydropic type usually grows at the margin of the adenoma or just below 
the capsule. A third type of neohepatocyte is called the pleomorphic type 
because of it's larger size and abnormally large nucleus with dense 
chromatin. Giant cell formation may occur in approximately 10% of 
hepatocellular adenomas. The overall growth pattern must be observed 
carefully to exclude malignant change, which is recognised by nodule-within-
nodule growth and by the presence of large trabeculae. The fourth type of 
neohepatocyte has a centrally located nucleus and clear cytoplasm with 
abundant glycogen. 
Cytoplasmic changes of other types may be noted in many hepatocellular 
adenomas. Alcoholic hyaline may be abundant. Cholestasis is often present, 
especially in the non-hydropic type. fatty hepatocytes are occasionally 
present and may be prominent in some hepatocellular adenomas. 
The architectural framework of hepatocellular adenoma consists of blood 
vessels and associated connective tissue that is usually scanty, but may form 
thin septae. Blood vessels are often very prominent at the margins and within 
the tumour. Although intimal fibrosis is present in capsular vessels, arterial 
branches within the tumour are free of such intimal thickening. The arteries 
within the hepatocellular adenoma are closely accompanied by veins. 
Degenerative changes may be present in the centre of the tumour, especially 
in larger hepatocellular adenomas (larger than 1 O cm) characterised by 
necrosis, haemorrhage, densely collagenous scarifications, perivascular 
oedema, and occasionally, angiomatoid vascular ectasia. Wide dilatation of 
the sinusoids is also common and results in peliosis hepatis. A distinctive 
fibrodegenerative lesion composed of poorly cellular masses of amorphous 
eosinophilic material within the dilated sinusoids may be observed. The 
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formation of a fibrous capsule occurs at the periphery of most tumours; 
although thin and incomplete, it is composed of poorly cellular collagenous 
connective tissue. 
Electron microscopic study of the hepatocellular adenoma has not disclosed 
diagnostic features. lntramitochondrial inclusions have been recorded, but 
are not specific. 
The neohepatocyte types in spontaneous hepatocellular adenoma in women 
are similar to those present in oestrogen-associated tumours. These tumours 
rarely undergo infarction and haemorrhage, however. One patient in the 
series of Craig et al. (1989) revealed prominent macrovesicular fatty change 
and another large, deeply acidophilic neohepatocytes associated with striking 
peliosis hepatis. 
Although adenomas occur occasionally in infants, in children or in men, they 
are not complicated by haemorrhage and rupture as those in women taking 
oral contraceptives. In spontaneous hepatocellular adenoma in men, the 
growth pattern is often characterised by nodularity due to fine fibrous 
septation. In one case in the series of Craig et al. (1989), the growth pattern 
was that of small nodules within larger ones, with associated infarction. In all 
cases, the cytoplasm is predominantly acidophilic with fewer hydropic forms. 
In spontaneous hepatocellular adenoma in children, the cytoplasm is also 
predominantly acidophilic and a mixture of hydrophilic forms is usually 
present. Occasionally, the neohepatocytes are dispersed in sheets with no 
definite cord pattern, while in some, the cord pattern is well defined and 
pericanalicular lipochrome may be present. In hepatocellular adenoma 
associated with metabolic disease, the histological appearance is identical to 
that of the more common oestrogen-related hepatocellular adenoma, with a 
predominantly acidophilic small cell growth pattern, although macrovesicular 
fat may predominate in the neohepatocytes (Coire et al., 1987). 
Pathological associations 
Hepatic cavernous haemangioma is frequently associated with cysts in the 
liver or pancreas (Feldman, 1958). Although Benz and Baggenstoss (1953) 
and Mathieu et al. (1989) found a high (20%) association of HCH with focal 
nodular hyperplasia (FNH), Ishak and Rabin (1975) found an association in 
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only 2,3% of livers and Ndimbie et al. (1990) observed only two cases (See 
Appendix 14). Matthieu et al. (1989) found no association between HCH and 
hepatocellular adenoma (HA). 
EPIDEMIOLOGY 
Prevalence 
Benign tumours of the liver, other than haemangiomas, are rare (Edmondson, 
1958; Ishak and Rabin, 1975; Nichols et al., 1989; Adam et al., 1970; Malt et 
al., 1970; Gold et al., 1978; Henson et al., 1956a) (See Appendix 15). 
The autopsy prevalence of benign liver tumours other than cavernous 
haemangioma is low, reported as 0.07 - 0.39 % in two major autopsy series 
(Edmondson, 1958 and Craig et al., 1989). Benign bile duct tumours in 
consecutive necropsies or liver needle biopsies has been reported in 0.6 -
2.8% of cases (Thommesen, 1978; Chung, 1970), while Poulsen and 
Christofferson (1979) found focal nodular hyperplasia in 1 - 2% of necropsy 
specimens. 
The most common benign liver tumour is the cavernous haemangioma 
( Geschickter and Keas bey, 1935; Henson et al., 1956b; Ochsner and Halpert, 
1958; Feldman, 1958; Ishak and Rabin, 1975; Adam et al., 1970; Walt, 1977; 
Karhunen, 1986; Wish now, 1989; Hobbs, 1990; Gandolfi et al., 1991; 
Yamamoto et al., 1991; lwatsuki et al., 1990). Of all the internal organs, the 
liver is the organ most commonly involved by cavernous haemangioma 
(Frerichs, 1861; Eckles, 1927; Major and Black, 1918; Shumacker and 
Baltimore, 1942; Henson et al., 1956b; Adam et al., 1970). Liver 
haemangiomas accounted for 109 of the 570 haemangiomas documented in 
a series at the Johns Hopkins Hospital (Geschickter and Keasbey, 1935). 
Hepatic haemangiomas are evenly distributed world-wide (Kew, 1990). 
After metastases, cavernous haemangioma is the most common of all the 
hepatic neoplasms, (Edmondson, 1958; Grieco and Miscall, 1978; Kew, 
1990). The high prevalence of metastases is very important when considering 
the predictive value of radionuclide imaging. Craig et al. (1989), in a review of 
91 000 autopsies reported a prevalence of liver metastases of 7.7%, while 
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lwatsuki et al. (1990) reported a prevalence of 33.8% in a surgical series of 
54 7 patients. 
The prevalence of HCH varies from 0.35 - 7.3% in autopsy series, with a 
mean of 0.87% (Edmondson, 1958; O'Donoghue and Nicosia, 1950; Craig et 
al., 1989; Adami, 191 O; Ochsner and Halpert, 1958; Feldman, 1958), 
although one autopsy series of 95 prospective consecutive medicolegal 
autopsies on men reported a prevalence of 20% (Karhunen, 1986). Two 
surgical series in which HCH was diagnosed in patients referred for resection 
of suspected neoplastic liver disease with a prevalence of 20%, may suffer 
from selection bias (Sinanan and Marchioro, 1989; lwatsuki et al. 1990). The 
52% prevalence of HCH reported by Little et al. (1990) in a study of hepatic 
lesions incidentally discovered on ultrasonography and/or CT imaging in 36 
patients and referred to a surgical unit for evaluation, may also reflect a 
selection bias. See Appendix 16. 
An increasing prevalence of HCH and other benign liver tumours reported in 
the literature probably reflects advances in diagnostic technology, rather than 
a true increase (Nichols et al., 1989). 
Age distribution 
Haemangiomas of the liver occur in all age groups (Frerichs, 1861; Wilson 
and Tyson, 1952; Nichols et al., 1989; Ishak and Rabin, 1975; Edmondson, 
1958; Berliner et al., 1983; Du Pre and Fincher, 1992; Kato et al., 1975; 
Canter and Longmire, 1988), but are rare in infants and children 
(O'Donoghue et Nicosia, 1950; Edmondson, 1958; Niemann and Penitschka, 
1957) and increase in frequency with advancing age (O'Donoghue and 
Nicosia, 1950; Frerichs, 1861; Mcloughlin, 1971; Karhunen, 1986). 
Symptoms are reported to occur most commonly between the ages of 45 - 50 
years (Tait et al., 1992; Canter and Longmire, 1988; Berk and Priest 1965). 
The peak prevalence of HCH is in the third to sixth decades of life (Wilson 
and Tyson, 1952; Shumacker and Baltimore, 1942; Gandolfi et al., 1991; 
Nichols et al., 1989; Du Pre and Fincher, 1992; Canter and Longmire, 1988; 
Kato et al., 1975; Starzl et al., 1980). (See Appendix 17). 
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Sex distribution 
A female preponderance of HCH with a mean female to male ratio of 2.8: 1 is 
reported in several surgical series (resection of symptomatic HCH), two 
clinical series (symptomatic HCH), one angiographic series and one autopsy 
study of 12 calcified (complicated) haemangiomas (Kato et al., 1975; Starzl et 
al., 1980; Wilson and Tyson, 1952; Adam et al., 1970; Reading et al., 1988; 
Lise et al., 1992; Vishnevsky et al., 1991; Nichols et al., 1989; Trastek et al., 
1983; Schwartz and Husser, 1987; lwatsuki et al., 1990; Bornman et al., 
1987; Shumacker and Baltimore, 1942; Mcloughlin, 1971; O'Donoghue and 
Nicosia, 1950; Alper et al., 1988; Plachta, 1962; Sinanan and Marchioro, 
1989). (See Appendix 17). In contrast, Edmondson (1958) and Craig et al. 
(1989) reported a male preponderance in their large autopsy series, with a 
mean female to male ratio of 0. 65: 1. See Appendix 17. In both series, 
however, patients under 40 years of age with HCH were predominantly 
female. 
Henson et al. ( 1956b ), found a female to male ratio of 10: 1 for his subgroup 
of patients with symptomatic haemangiomas, but the ratio for the subgroup 
with incidentally discovered haemangiomas was 3.8:1 (5:1 for the entire 
group). Trastek et al. (1983), in a clinical study of patients with liver 
cavernous haemangioma larger than 4 cm, found that the female group had a 
mean age of 40 years as opposed to 55 years for the male group. In 
summary, the discordance of the female to male ratio between series of large 
and/or symptomatic HCH or surgical resection of HCH and autopsy series, 
support the opinion in the literature that haemangiomas in females are more 
prone to become clinically manifest and at an earlier age than in males, 
(Edmondson, 1958; Shumacker and Baltimore, 1942; Nichols et al., (1989). 




The great majority of cavernous haemangiomas of the liver are small, 
asymptomatic and discovered incidentally on abdominal examination, at 
laparotomy, autopsy (Shumacker and Baltimore, 1942; Park and Philips, 
1970; Bornman et al., 1987; Ishak and Rabin, 1975), or by ultrasonography, 
computerised tomography or angiography performed for other reasons in 
patients who have symptoms unrelated to the tumour itself (Johnson et al., 
1981; Adson, 1986; Freeny et al., 1979; Bornman et al., 1987; Reading et al., 
1988; Park and Philips, 1970). The frequency of asymptomatic forms in the 
literature varies from 68.6% to 86.5% (Adam et al., 1970; Henson et al., 
1956a; Park and Philips, 1970). This may be due to the availability of 
ultrasonography and computerised tomography which detects lesions that 
would previously have been missed. In the evaluation of the oncological 
patient, incidentally found haemangiomas frequently raise concern about 
metastases (Scatarige et al., 1987; Shimizu et al., 1990; Wishnow et al., 
1989; Mydlo et al., 1991 ). 
Liver haemangiomas rarely become symptomatic, even when large and 
palpable (Kato et al., 1975). The percentage of patients with liver 
haemangiomas who are symptomatic range in the literature from 6.5 to 13.5% 
(Gandolfi et al., 1991; Park and Philips, 1970). Clinical studies have reported 
symptomatology developing only in patients with liver haemangiomas 
exceeding 4 cm (Adam et al., 1970) or 10 cm (Nichols et al., 1989) in 
diameter. When haemangiomas reach a size sufficient to exert pressure on, 
to displace, or to interfere with the normal functioning of adjacent viscera and 
organs, they may present with a sensation of pressure, weight, fullness or 
dragging discomfort in the upper abdomen and may be associated with 
anorexia, nausea and vomiting or dysphagia (Morley et al., 197 4; Issa, 1968; 
Wilson and Tyson, 1952; Grieco and Miscall, 1978; Ishak and Rabin, 1975; 
Abrams et al., 1969). Liver haemangiomas may present with an increasing 
abdominal girth or an upper abdominal mass, non-specific abdominal pain 
almost always located in the right upper quadrant or epigastrium with 
frequent radiation to the back and right shoulder (Morley et al., 197 4; Grieco 
and Miscall, 1978; lwatsuki et al., 1990; Bornman et al., 1987). Pain is 
probably due to stretching and inflammation of Glisson's capsule (Nichols et 
al., 1989), which may be caused by recurrent or intermittent thromboses 
causing the lesion to swell and producing focal fibrinous serositis, or due to 
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compression of adjacent organs such as the stomach, gallbladder or bile 
ducts (Nichols eta/., 1989; Goodman, 1987; Taitelbaum eta/., 1982; Gandolfi 
et al., 1991 ). The primary symptoms are increased abdominal girth, vague 
abdominal pain and non-specific digestive disturbances (Levitt et al., 1955) 
and about half of the patients coming to surgery are aware of an enlarging 
abdomen or a localized abdominal swelling (Morley et al., 1974). 
Although physical examination is often unremarkable (Du Pre and Fincher, 
1992; Nichols et al., 1989), the most common physical finding is that of a 
palpable mass in the right upper quadrant connected to the liver, the tumour 
moving with respiration (Shumacker and Baltimore, 1942; Henson et al., 
1956b; Morley et al., 1974; Berk and Priest, 1965). The liver itself may or may 
not be enlarged, or may reveal the fine nodularity and firm consistency of 
cirrhosis (Berk and Priest, 1965). The lesion is usually non-tender, smooth 
and varies considerably in size (Berk and Priest, 1965; Grieco and Miscall, 
1978). Haemangiomas may be soft, spongy and compressible ( depending on 
the amount of fibrosis of the haemangioma and/or its capsule, liver 
haemangiomas may occasionally be of firm or hard consistency (Wakeley, 
1925)). Occasionally a bruit or venous hum is audible (Berk and Priest, 1965; 
Grieco and Miscall, 1978; Morley et al., 1974; Nichols et al., 1989; Levitt et 
al., 1955). 
Less common presentations include episodes of acute abdominal pain which 
may be caused by congestion, thrombosis or infarction (Bornman et al., 1987; 
Ishak and Rabin, 1975; Taitelbaum et al., 1982; Kew, 1990; Berk and Priest, 
1965), acute haemorrhage into the haemangioma (Issa, 1968), or an acute 
abdominal crisis due to haemoperitoneum resulting from spontaneous or 
traumatic rupture (Ishak and Rabin, 1975; Kew, 1990; Nichols et al., 1989, 
Taitelbaum et al., 1982; Stayman et al., 1976; Kawarada and Mizumoto, 
1984). Rupture is a catastrophic event and carries a 67% to 70% mortality 
(Taylor et al., 1981; Sewell and Weiss, 1961; Niemann and Penitschka, 
1957). The reported incidence of spontaneous rupture ranges from 0.9% to 
4.5% (Adam et al., 1970; Shumacker and Baltimore, 1942) From the small 
number of cases reported in the literature, this complication appears to be 
extremely rare (Taylor et al., 1981; Sewell and Weiss, 1961; Zafrani, 1989; 
Trastek et al., 1983; Yamamoto et al., 1991 ). See Appendix 18. 
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Rupture of the haemangioma may present with a sudden unexplained shock 
or may mimic the presentation of an acute abdominal emergency such as 
acute appendicitis, perforated peptic ulcer, acute diverticulitis or ruptured 
tubal pregnancy (Wilson and Tyson, 1952; Levitt et al., 1955). Diagnostic 
liver biopsy or incision at operation can result in massive haemorrhage which 
may be fatal (Levitt et al., 1955). 
Other rare complications of haemangiomas include obstructive jaundice (Kato 
et al., 1975), biliary colic (Levitt et al., 1955), obstruction of the gastric cardia 
(Wakeley, 1925), torsion of pedunculated haemangiomas (Berk and Priest, 
1965; Tran-Minh et al., 1991) and abscess formation following percutaneous 
liver biopsy (Klein et al., 1980). Berliner et al. ( 1983) reported abscess 
formation 6 months following biopsy, raising the possibility of spontaneous 
formation. 
A clinical triad of rigor, pyrexia and right upper quadrant tenderness, with or 
without hepatomegaly in the presence of a normal leucocyte count, with or 
without abnormal liver function tests and with a raised ESR and serum 
fibrin(ogen) breakdown products, suggests that the haemangioma has been 
complicated by infective bleeding, thrombosis and/or infarction. These 
manifestations return to normal following resection of the haemangioma. 
These features are also commonly found in hepatocellular carcinoma 
complicated by necrosis and therefore this triad should prompt aggressive 




As with other benign hepatic tumours, hepatic function tests are usually 
normal and thus of little help in the diagnosis (Berk and Priest, 1965; Henson 
et al., 1956b; Shockman et al., 1963; Nichols et al., 1989; Park and Philips, 
1970; Schwartz and Husser, 1987; Taitelbaum et al., 1982). However, Little et 
a/. (1990) showed that one or more values of bilirubin, serum alkaline 
phosphatase, serum alanine amino transferase or serum gamma glutamyl 
transpeptidase, were abnormal in 8 of 21 patients with incidentally discovered 
benign liver lesions. Occasionally, slight elevation of bilirubin level (Henson 
et al., 1956b; Gandolfi et al., 1991 ), alkaline phosphatase (Bornman et al., 
1987), alkaline phosphatase and serum gamma glutamyl transferase 
(Pateron et al., 1991; Reading et al., 1988) or of all three (Gandolfi et al., 
1991) have been reported in patients with large symptomatic haemangiomas. 
(See Appendix 19). 
Compression of bile ducts due to large or enlarging central haemangiomas, 
particularly in the presence of greater rigidity produced by acute 
haemorrhage, thrombosis and/or fibrosis, may cause raised bilirubin, ALP 
and/or GGT. Portal vein compression has been demonstrated 
angiographically in some cases (Gandolfi et al., 1991 ). Enzyme activity and 
bilirubin return to normal following radiotherapy (Henson et al., 1956b) and 
surgical resection (Pateron et al., 1991; Bornman et al., 1987). Whereas 
abnormal liver function tests are only infrequently found associated with 
hepatic cavernous haemangioma, primary or secondary malignant tumours of 
the liver are commonly associated with abnormal liver function tests (Kemeny 
et al., 1982; Chu and Douglass, 1986). 
Tumour markers such as alpha fetoprotein and carcinoembryonic antigen are 
negative in isolated haemangioma (Reading et al., 1988; Little et al., 1990; 
Bornman et al., 1987). 
Rarely, large hepatic haemangiomas may cause the Kasabach-Merritt 
syndrome, a thrombocytopaenia microangiopathic haemolytic anaemia 
consumptive coagulopathy, attributed to sequestration and destruction of 
platelets and red cells in haemangiomas (Shimitsu et al., 1990; lnceman and 
Tangun, 1969; Cooper and Martin, 1962). Kawarada and Mizumoto (1984) 
reported the prompt cure of Kasabach-Merritt syndrome in two patients 
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following resection of large haemangiomas. 
Hypofibrinogenaemia may also occur and is associated with increased 
fibrin(ogen) degradation products, indicating a fibrin(ogen)olytic process 
(Behar et al., 1963; Martinez et al., 1973; Shimitsu 1990; lnceman and 
Tangun, 1969). This is thought to be secondary to coagulation and fibrin clot 
deposition in the haemangioma (Behar et al., 1963), or to primary activation 
of fibrinolysis possibly by a plasminogen activator released by the 
endothelium, with little or no activation of intravascular coagulation (Martinez 
et al., 1973). 
Microangiopathic haemolytic anaemia ( decreased erythrocytes, haemoglobin 
and haptoglobin, increased indirect bilirubin and red cell fragments) in 
association with chronic defibrination may occur in cavernous haemangioma 
(lnceman and Tangun, 1969; Shimitsu et al., 1990). This is usually 
associated with thrombocytopaenia (lnceman and Tangun, 1969) but rarely 
with a normal platelet count, possibly due to increased platelet turnover 
(Shimitsu et al., 1990). 
Rarely, polycythaemia may occur secondary to abnormal secretion of a 
biologically active erythropoietin by haemangiomas. However, erythrocytosis 
associated with hepatic tumour is most commonly seen with hepatocellular 
carcinoma (Taillan et al., 1989; Davidson, 1976). 
TECHNETIUM 99M ERYTHROCYTE BLOOD POOL 
SCINTIGRAPHY 
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Labelling of erythrocytes with Technetium 99m (99mTc) provides a suitable 
intravascular blood pool imaging agent. This is in contrast to the previously 
used agents such as 113mtndium transferrin, 131 Iodine- and 99mTc - labelled 
human serum albumin and s1 Chromium labelled erythrocytes, which were not 
suitable for modern gamma cameras, had low labelling efficiency and 
diffused out of the intravascular space (Front et al., 1984). High labelling 
efficiency is achieved by consecutive treatment of the red cells with stannous 
ion and 99mTc pertechnetate and is complemented by the favourable physical 
properties and efficient detection of the 99mTc emissions by the modern Anger 
camera. The Technetium is bound to the beta chain of the haemoglobin 
molecule (Dewanjee, 1974) with maintenance of cellular integrity and high 
stability of the cellular label both in vivo and in vitro. Labelling may be 
performed in vivo, by a combined in vivo/in vitro technique or by an in vitro 
technique, with labelling efficiency increasing respectively from former to 
latter method. Labelling performed in vitro is associated with little free 99mTc 
pertechnetate, as opposed to in vivo labelling, providing a higher target to 
backround ratio and thus improving sensitivity of detection, especially for 
small and/or thrombotic or fibrotic liver haemangiomas (Floyd, 1986; 
Rabinowitz eta/., 1984; Brodsky eta/., 1987). 
Hepatic blood pool scintigraphy can be performed as planar scintigraphy in 
isolation or augmented by single photon emission computerized tomography 
(SPECT). 
Planar blood pool scintigraphy comprises three phases. Methods described 
in the literature are varied: 
1. The perfusion, blood flow or dynamic phase (radionuclide 
angiography), during which data is acquired at a framing rate of between 
1 and 5 seconds per frame for 30 to 120 seconds, following rapid bolus 
administration of labelled erythrocytes. The projection chosen for 
radionuclide angiography is that which best visualizes the mass lesion; its 
position having been determined by other methods. 
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2. The early blood pool phase, during which images are acquired in one 
or more projections immediately following the perfusion phase, with or 
without additional images acquired at variable intervals up to 30 minutes. 
3. The late blood pool phase, during which images are acquired at 1 to 2 
hours following administration of labelled erythrocytes. 
Radionuclide angiography was performed in the majority of studies reviewed, 
although certain authors have excluded the perfusion phase and relied 
entirely on information obtained from late blood pool imaging, with or without 
early blood pool phase imaging (Birnbaum et al., 1990; Brown et al., 1987; 
Guze and Hawkins, 1989; Krause et al., 1993; Kudo et al., 1989; Langsteger 
et al., 1989; Lipman and Tumeh, 1990; Malik, 1987). 
Planar blood pool scintigraphy is performed with the acquisition of 500 000 to 
3 000 000 (usually 1000 000) counts on a large field of view Anger camera 
equipped with a low energy high resolution or general purpose collimator, on 
a 128 by 128 or 256 by 256 acquisition matrix. 
Single photon emission computerised tomography (SPECT) is typically 
performed on a single rotating head Anger camera with the acquisition of 64 
to 128 angular projections over a 360 degree rotation, with images acquired 
for 10 to 45 seconds (usually 20 to 30 seconds) or 300 000 counts per 
projection, on a 64 by 64 acquisition matrix. SPECT performed on a dual 
head rotating camera typically comprises the acquisition of 64 angular 
projections with 32 angular intervals of 40 seconds each over 180 degrees 
(Krause et al., 1993). SPECT acquired on a three headed camera typically 
comprises the acquisition of 120 angular projections over 360 degrees 
(Ziessman et al., 1991 ). SPECT acquisition may be performed at 1 to 2 hours 
following labelled erythrocyte administration. Brunetti et al. (1988) performed 
acquisition at 10 minutes following administration and found superior 
sensitivity to planar scintigraphy performed at 1 hour post administration. 
Langsteger et al. ( 1989) performed acquisition at 30 and 120 minutes and 
found that although enhanced activity was evident in all the haemangiomas 
studied, the accumulation of labelled erythrocytes was greater in the 2 hour 
study. Reconstruction of SPECT data is performed by filtered backprojection, 
but consensus regarding the filter type is lacking in the literature and filters 
include ramp, Hanning, ramp-Hanning and Butterworth. Correction for centre 
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of rotation and camera non-uniformity is performed commonly, while 
correction for attenuation is performed in a minority of studies (Brunetti et al., 
1988; Kudo et al., 1989). Generation of orthogonal planes in three axes 
(transaxial, sagittal and coronal) of one pixel (6 mm) width or successive 
merging of two adjacent pixels (12 mm) may be performed. 
In the blood pool phase, early and delayed planar scintigraphy are commonly 
performed alone (Front et al., 1981; Front et al., 1984; Lisbona et al., 1989; 
Moinuddin et al., 1985; Rabinowitz et al., 1984; Rossleigh et al., 1984) or in 
combination with delayed SPECT (Brodsky et al., 1987; Groshar et al., 1992; 
Kudo et al., 1989; Lipman and Tumeh, 1990; Farlow et al., 1990; Tumeh et 
al., 1985; Tumeh et al., 1987; Birnbaum et al., 1990; lntenzo et al., 1988; 
Swayne et al., 1991; Ziessman et al., 1991 ). Less common imaging methods 
include delayed planar scintigraphy only (Brown et al., 1987), delayed planar 
scintigraphy and SPECT without early planar scintigraphy (Malik, 1987; 
Krause et al., 1993) and delayed SPECT only (Guze and Hawkins, 1989; 
Langsteger et al., 1989). 
Planar blood pool scintigraphy 
The perfusion blood pool mismatch, generally considered diagnostic for 
hepatic cavernous haemangioma (Rabinowitz et al., 1984; Engel et al., 1983; 
Drane et al., 1987; lntenzo et al., 1988; Moinuddin et al., 1985; Front et al., 
1983; Groshar et al., 1992), embraces the combination of absent or only 
partial perfusion of the lesion and slow progressive filling with labelled 
erythrocytes over time, i.e. complete or near complete in the late blood pool 
phase (at 1-2 hours post injection), reflecting a lesion with slow perfusion but 
large blood pool. A mismatch may also be present between the early blood 
pool phase (immediately following the dynamic or perfusion phase up to 
approximately 30 minutes post injection) and the late blood pool phase. The 
basis of the perfusion blood pool mismatch and also of an early blood 
pool/late blood pool mismatch, may be the sluggish circulation of blood 
through the tortuous cavernous spaces of the haemangioma, producing slow 
ingress and egress of the label, with the radioactive blood entering the 
haemangioma being rapidly diluted initially by the large volume of non-
radioactive blood contained therein (Good et al., 1978; Wilcox and Joo, 1980; 
Front et al., 1983). Hence, hepatic cavernous haemangioma typically reveals 
decreased activity relative to the adjacent parenchyma in the dynamic phase 
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and characteristically reveals activity increased relative to adjacent hepatic 
parenchyma in the late blood pool phase, with or without progressive 
increase of lesion activity intensity from early to late blood pool phases. 
Visualisation of the entire extent of the lesion requires complete mixing of the 
labelled erythrocytes with the non-labelled blood contained within the 
haemangioma. The extent to which the lesion is visualised depends upon the 
degree of admixture achieved which in turn depends upon the size of the 
haemangioma, i.e. the contained volume, as well as the length of time 
between injection and imaging (Front et al., 1984). In small haemangiomas, 
admixture with the non-labelled blood is more rapid and they can be 
visualised in the early blood pool phase (Groshar et al., 1992), often earlier 
than large cavernous haemangiomas, where the larger contained volume of 
non-radioactive blood delays visualisation. In the former, activity may be 
intense in the early blood pool phase and remains constant into the late 
blood pool phase. Calculation of peak filling rates reveals that maximal 
labelled erythrocyte accumulation typically occurs within 30-50 minutes after 
injection (Drane, 1991 ). If early blood pool images are performed before 
mixing is complete, and late blood pool images are not done, the slowly filling 
pool of blood, typical of haemangiomas, will be missed, giving a false 
negative result (Good et al., 1978; Wilcox and Joo, 1980). This emphasizes 
the importance of late blood pool imaging, since it is only at this stage that 
the entire extent of the lesion, often underestimated by 99mTc sulphur colloid 
scintigraphy, is visualised (Front et al., 1984). Even so, non-visualization of 
the haemangioma in the late blood pool phase may occur with extensive 
thrombosis, fibrosis or infarction of the haemangioma, or with small lesions ( < 
1.5 cm), especially when deeply situated in the liver tissue (Rabinowitz et al., 
1984). 
Variable appearance of HCH in dynamic and early blood pool phases 
1 . Haemangiomas, especially smaller or deeply situated lesions, may appear 
isoactive with the adjacent parenchyma in the dynamic phase. During the 
early blood pool phase, a variable portion of the lesion may reveal some 
degree of activity accumulation. 
2. While peripheral contrast enhancement is found frequently with 
cavernous haemangioma on dynamic bolus CT imaging (Freeny and 
Marks, 1986b), peripheral followed by centripetal filling is rarely seen with 
blood pool scintigraphy, but when demonstrated is highly suggestive if not 
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pathognomonic, of hepatic cavernous haemangioma (El Desouki et al., 
1991; Kim et al., 1987; Drane and Weatherby, 1988). The reason for the 
discrepancy between these techniques is due to fundamental differences 
between planar (blood pool) and cross sectional (CT) imaging. Planar 
imaging of a peripherally filling spherical mass would show activity 
throughout the mass, because the surface of the mass is presented en 
face to the camera, as opposed to the true cross sectional visualization 
seen with CT imaging (Drane and Weatherby, 1988). In a sufficiently 
large haemangioma, greater superimposition of the marginal than the 
central activity may render an appearance of greater detectable activity in 
the outer margin than in the centre of the lesion on planar scintigraphy. 
The pattern of fill-in also appears to be size dependant, with larger lesions 
(greater than 10-11 cm) revealing peripheral followed by centripetal filling 
and smaller lesions equilibrating uniformly (Groshar et al., 1992; Lisbona 
et al., 1989). Single photon emission computerized tomography (SPECT) 
is not expected to increase the detection of early peripheral and 
progressive centripetal filling, in spite of its cross sectional nature, 
principally because SPECT imaging is usually performed at 60-120 
minutes post-injection, at which stage the greatest amount of admixture 
and central filling has already been attained (Drane and Weatherby, 
1988). 
3. The uncommon atypical appearance of HCH consists of increased activity 
either in the early (arterial) or the mid dynamic phase, usually in a small 
portion of the haemangioma, but occasionally involving most of the lesion 
(Front et al., 1984; Brodsky et al., 1987). Usually the atypical appearance 
is associated with unchanging or increasing activity intensity from the 
dynamic through to the delayed blood pool phase (Larcos et al., 1989). It 
is unclear why some haemangiomas demonstrate increased early activity 
in addition to progressive or persistent heightened blood pool activity, but 
it may be related to the presence of larger less tortuous sinusoidal 
cavernous spaces or arteriovenous communications within the 
haemangioma, which may permit rapid ingress of radioactive blood, yet 
with sufficiently delayed outflow to allow activity to persist in the delayed 
blood pool. Hardoff et al. (1989) described a reversing vascular pattern, 
whereby a small central portion of a haemangioma revealed increased 
arterial flow initially and reduced blood pool activity subsequently, while 
the periphery of the lesion revealed decreased arterial flow initially and 
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increased blood pool activity subsequently. This pattern suggests the 
presence of a separate blood supply with larger diameter vessels of 
lesser tortuousity in the central portion surrounded by the usual tortuous 
cavernous spaces. 
False positive blood pool scintigraphy - hepatoce/lular carcinoma and 
metastases 
While hepatocellular carcinoma and some vascular metastases may 
demonstrate increased activity in the perfusion and immediate blood pool 
phases, they usually demonstrate isoactivity or hypoactivity relative to 
adjacent liver parenchyma in the late blood pool phase (Front et al., 1984; 
Swayne et al., 1991; Kudo et al., 1989; Rabinowitz et al., 1984). Four cases of 
hepatocellular carcinoma with increased activity in the perfusion and the late 
blood pool phases, are described in the literature (lntenzo et al., 1988; 
Rabinowitz et al., 1984; Drum, 1982). Conversely, none of the 46 
hepatocellular carcinomas in the study of Kudo et al. (1989), had delayed 
blood pool activity on planar or SPECT imaging. One case of metastatic 
colon carcinoma and one of metastatic adenocarcinoma, both with increased 
activity relative to adjacent parenchyma on delayed SPECT have been 
reported, but in both cases, the labelled erythrocyte accumulation is 
considered to have occurred in immediately adjacent areas of focal 
sinusoidal dilatation and congestion, rather than in the metastasis itself 
(Swayne et al., 1991; Ali et al.,1994). These non-specific reactive changes 
are commonly seen in the vicinity of space-occupying hepatic lesions (Gerber 
et al., 1986). 
Decreased perfusion was not present in any of the hepatocellular carcinomas 
or metastases described in the literature demonstrating false positive 
increased activity in the late blood pool phase. This substantiates the 
consensus in the literature that the presence of such a perfusion blood pool 
mismatch is considered pathognomonic for HCH. These tumours revealed 
increased (the hepatocellular carcinomas) and normal (the metastases) 
perfusion, but lesion activity which was increased in the late blood pool 
phase, a pattern which may be confused with that of a hepatic cavernous 
haemangioma. When increased perfusion is present in a lesion, the 
observation of clearly progressive accumulation of activity over time from the 
perfusion to the late blood pool phase, may help distinguish between an 
atypical haemangioma and a hepatocellular carcinoma or vascular 
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metastasis ( Larcos et al., 1989; Drane, 1991 ) . Owing to the nature of the 
(slow) portal blood supply and prolonged mixing phase of haemangiomas as 
opposed to the hepatic arterial supply of hepatocellular carcinoma, 
quantitative analysis (by the utilization of time activity curves obtained from a 
region of interest around the lesion) of early and late blood pool phase 
activity intensity may improve accuracy, but requires further validation 
(Moinuddin et al., 1985). 
False positive blood pool scintigraphy - angiosarcoma 
Ginsberg et al. (1986) reported an angiosarcoma which presented with an 
early blood pool - late blood pool mismatch, thereby mimicking the 
appearance of hepatic cavernous haemangioma. He postulated that the 
scintigraphic features may have occurred due to histological similarities 
between the highly vascularized angiosarcoma and hepatic cavernous 
haemangioma. 
False negative blood pool scintigraphy - isoactive lesion pattern of HCH 
A pattern of blood pool isoactivity may occur in patients with HCH if the lesion 
is small ( < 2 cm), deep seated location, or if partial thrombosis, infarction or 
fibrosis is present. The low tracer concentration in the lesion leads to poor 
resolution because of high background activity inherent in blood pool studies 
(Engel et al., 1983; Rabinowitz et al., 1984). While blood pool scintigraphy 
may be negative in the presence of HCH, primary or metastatic carcinoma of 
the liver usually give an isoactive blood pool image (Engel et al., 1983; Taylor 
et al., 1976). An isoactive late blood pool image obtained in the presence of a 
known mass lesion, therefore indicates the need for further investigation. 
False negative blood pool scintigraphy - hypoactive lesion pattern of 
HCH 
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When a liver haemangioma is largely replaced by thrombosis, infarction or 
fibrosis, an area of persistent hypoactivity or a mixed pattern of photopaenia 
with focal areas of increased activity contained therein, may be seen on 
blood pool images (Karimeddini and Klein, 1991; lntenzo et al., 1988; 
Rabinowitz et al.., 1984 ). Either pattern requires further investigation to 
distinguish a complicated haemangioma from hepatocellular carcinoma or 
vascular metastasis with variable irregular necrosis and patchy late pooling. 
Differentiation of HCH from other lesions 
Focal nodular hyperplasia and hepatic adenomas usually reveal normal or 
increased activity in the early perfusion phase, with activity equal to adjacent 
parenchyma in the blood pool phase. 
SPECT blood pool scintigraphy 
Planar hepatic blood pool scintigraphy is thought to be a sensitive, specific 
and reliable technique for the evaluation of hepatic haemangioma and in 
distinguishing these from other benign and malignant hepatic lesions 
(Brunetti et al., 1988; Farlow et al., 1990; Front et al., 1981; Rabinowitz et al., 
1984). The SPECT technique may be more accurate than planar scintigraphy 
where haemangiomas are extensively fibrosed, and little pooling of labelled 
erythrocytes occurs (Rabinowitz et al., 1984), and in detecting small, deeply 
situated cavernous haemangiomas (Langsteger et al., 1989; Tumeh et al., 
1987; lntenzo et al., 1988; Brodsky et al., 1987; Drane, 1991; Rubin and 
Lichtenstein, 1993), and/or where small haemangiomas are obscured by 
adjacent normal vascular structures (Brunetti et al., 1988). 
SPECT provides two major advantages over conventional planar imaging 
(Keyes, 1989): 
Improved image contrast is achieved by SPECT, as superimposed tissue 
activity is removed (Keyes, 1989; Guze and Hawkins, 1989; Tumeh et al., 
1987; Brodsky et al., 1987; Bonnano et al., 1991; lntenzo et al., 1988; 
Langsteger et al., 1989; Malik, 1987). The smallest haemangioma identified 
on SPECT was 1.4 cm and by planar imaging 1. 7 cm (Kudo et al., 1989). 
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SPECT has a low sensitivity for detecting lesions smaller than 10-15 mm and 
planar imaging lesions less than 25-40 mm. (Langsteger et al., 1989). 
Advances in SPECT imaging techniques include dynamic three view display, 
high resolution SPECT and dynamic SPECT. Dynamic three view display is 
superior to conventional static display (Krause et al., 1993), while high 
resolution three headed SPECT may allow visualization of 20-30% of 
haemangiomas of 0.5 - 1.3 cm in diameter (Ziessman et al., 1991 ). Small 
haemangiomas (### 5 mm) may be difficult to distinguish from normal 
vascular anatomy and variation in hepatic blood pool background (Drane, 
1991 ). Dynamic three headed SPECT, with sequential acquisitions over time, 
permits the visualization of cavernous haemangiomas 5 mm in diameter while 
avoiding confusion over normal vascular anatomy, and the calculation of 
peak filling rates. This method combines the increased sensitivity of high 
resolution SPECT with the increased specificity and characterization value of 
analyzing progressive RBC accumulation (Drane, 1991 ). 
Correlation of SPECT with other cross sectional imaging modalities such as 
ultrasound and CT imaging, particularly in the evaluation and precise 
anatomic location of small lesions (Brunetti et al., 1988; Brodsky et al., 1987; 
Birnbaum et al., 1990), is also better. The SPECT technique may, in addition, 
give better resolution of the size, relative position, anatomy and the 
delineation of small lesions adjacent to vascular structures, by virtue of its 
ability to provide a three dimensional map of liver tracer distribution (Guze 
and Hawkins, 1989; Brunetti et al., 1988; Oyamada et al., 1984; Brodsky et 
al., 1987; Birnbaum et al., 1990; Ziessman et al., 1991). The three 
dimensional image is obtained because the gamma camera collects data 
from a volume, and not a single slice, as is the case in conventional 
transmission X-ray and computerised tomographic (CT) techniques (Keyes, 
1989; Brunetti et al., 1988). The three dimensional resolution of SPECT also 
improves correlation of scintigraphy with CT and ultrasound techniques, 
allowing precise localisation of lesions (Guze and Hawkins, 1989; Brunetti et 
al., 1988; Oyamada et al., 1984; Brodsky et al., 1987; Birnbaum et al., 1990; 
Ziessman et al., 1991 ). 
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Sensitivity of 99mTc blood pool scintigraphy for HCH 
The reported sensitivity for detection of HCH by planar blood pool 
scintigraphy varies between 33 and 89% depending on the size of the lesion 
(Brunetti et al., 1988; Engel et al., 1983; Kudo et al., 1989; Langsteger et al., 
1989; Malik, 1987; Rabinowitz et al., 1984; Farlow et al., 1990; Tumeh et al., 
1987). Sensitivity was 16 - 50% for lesions smaller than 3 cm (Langsteger et 
al., 1989; Malik, 1987; Kudo et al., 1989) and 10% for lesions smaller than 
1. 5 cm (Brunetti et al., 1988). 
Reported sensitivity for SPECT blood pool scintigraphy varies between 58 
and 100% (Brunetti et al., 1988; Kudo et al., 1989; Langsteger et al., 1989; 
Malik, 1987; Farlow et al., 1990; Tumeh et al., 1987; Birnbaum et al., 1990), 
with up to 92% of lesions smaller than 3 cm (Langsteger et al., 1989; Malik, 
1987) and 28% of lesions smaller than 1.5 cm (Brunetti et al., 1988) being 
detected. Kudo et al. (1989) found a sensitivity of 85% for lesions larger than 
1.4 cm. Ziessman et al. (1991 ), demonstrated improved sensitivity with high 
resolution three-headed SPECT over previously reported results obtained 
with single-headed SPECT, and improved ability to detect small hepatic 
cavernous haemangiomas. Sensitivities of 100% for lesions greater or equal 
to 1.4 cm, 33% for lesions 0.9 -1.3 cm and 20% for lesions smaller than 0.8 
cm were demonstrated, while the smallest lesion visualized was 0.5 cm. 
Planar and SPECT blood pool scintigraphy (Langsteger et al., 1989; Malik, 
1987) have similar sensitivity for lesions > 3 cm. 
Specificity of 99mTc blood pool scintigraphy for HCH 
Of critical importance in the investigation of HCH, is the specificity of the test 
used in diagnosis. A false positive diagnosis of HCH as a benign lesion which 
usually does not require further treatment, may result in further investigation 
and management being stopped. Specificity of the test for HCH is thus of 
greater importance than sensitivity, as a false negative test for HCH will lead 
to further investigation, if clinically indicated. 
Despite the clear clinical importance of test specificity in HCH, all studies on 
the diagnostic accuracy of red-cell labelled blood pool scintigraphy done to 
date, have examined surprisingly few patients with lesions other than 
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haemangiomas. Clearly, if only HCH lesions are studied, only HCH will be 
detected, and test specificity will be 100%. Bayesian analysis (Patrick, 1979) 
clearly shows that the specificity of a test is dependant on the pre-test 
probability of the lesion being present and that the probability of a false 
positive result is directly proportional to the number of non-haemangiomatous 
cases studied. In addition, it is critical to avoid diagnosing HCH exclusively 
on the basis of a positive scintigraphic test. This bias was introduced in some 
of the studies of the accuracy of scintigraphy in HCH. The specificity and 
positive predictive value reported in the literature for planar and SPECT 
blood pool scintigraphy are 100% (Engel et al., 1983; Brunetti et al., 1988; 
Krause et al., 1993; lntenzo et al., 1988; Farlow et al., 1990; Tumeh et al., 
1987; Kudo et al., 1989; Ziessman et al., 1991). In these studies, the number 
of haemangiomas detected ranged between 11 and 108 (mean 36) and the 
number of patients between 9 and 77 (mean 26.5) respectively. 
Proportionately fewer non-HCH lesions were studied, with a range of 5 to 46 
(mean 18.6), in 5 to 29 patients (mean 14) respectively. The study with the 
largest non-haemangiomatous lesion group was that of Kudo et al. (1989) -
29 patients with a total of 46 hepatocellular carcinomas, as opposed to 77 
patients with a total of 108 haemangiomas. The small numbers of control 
patients means that the specificity of scintigraphy has never been adequately 
tested. In addition, in the studies by Engel et al (1983), lntenzo et al (1988), 
Kudo et al (1989) and Ziessman et al (1991 ), it is not clear that patients who 
received a diagnosis of HCH by scintigraphy, had this diagnosis confirmed by 
other means. It is thus not clear from these studies whether patients with non-
HCH lesions were included in the HCH group. This would also give a falsely 
high specificity for the test. 
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INVESTIGATION WITH OTHER RADIONUCLIDES 
ssmTc Sulphur Colloid (SC) 
The appearance of cavernous haemangioma, metastasis, hepatoma and the 
vast majority of hepatic adenomas on 99mTc sulphur colloid scintigraphy, is 
that of a photopaenic defect, thus rendering differentiation difficult (Drane et 
al., 1987; Antar et al., 1989; Kerlin et al., 1983; Lubbers et al., 1987). The 
double sequential in vivo labelling of the reticuloendothelial system and of 
erythrocytes, provides high accuracy detection of haemangiomas as focal 
defects on the colloid scintigraphy that subsequently fill in with labelled 
erythrocytes (Piga et al., 1990). 
Focal nodular hyperplasia may reveal decreased (in up to 30% of cases), 
normal or increased activity uptake (Drane et al., 1987; Welch et al., 1985; 
Rogers et al., 1981 ). Intense colloid uptake, seen in 10% of cases, is specific 
for focal nodular hyperplasia (Piers et al., 1980). 
99mTc Diisopropyldiacetic Acid (DISIDA) 
Metastases and cavernous haemangiomas appear as photopaenic defects on 
99mTc-DISIDA scintigraphy, although the latter may appear isoactive in the 
early images due to the amount of tracer activity present in the enlarged 
blood pool (Drane et al., 1987; Lecklitner and Dornbluth, 1985; Makler et al., 
1983). 
Hepatoma is usually photopaenic in the early part of the study (first 30 min), 
but may reveal uptake on the 1-5 hour delayed images without washout 
occurring. Focal nodular hyperplasia and hepatic adenoma reveal uptake and 
accumulation with poor washout and without washout respectively (Drane et 
al., 1987). 
99mTc Diethylenetriaminepentaacetic Acid (DTPA) 
Accumulation of 99mTc-DTPA in hepatic cavernous haemangiomas, probably a 
reflection of the enlarged blood pool, has been identified incidentally on renal 
scintigraphy (Moreno et al., 1987; Cabahug et al., 1989). 
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99mTc Methylenediphosphonate (MDP) 
Hepatic cavernous haemangiomas, occasionally accumulate 99mTc-MDP 
either on the basis of expanded and uncleared blood pool activity or septal 
calcification (Burkhalter et al., 1986; Le Bel et al., 1988). Hepatocellular 
carcinoma has also been shown to accumulate 99mTc-MDP on the basis of 
calcification, or in the absence of demonstrable microscopic or macroscopic 
calcification, on the basis of other, as yet poorly elucidated and probably 
multiple, pathophysiological factors operative in neoplasms (Desai, 1983). 
Gallium 67-Citrate 
Liver cavernous haemangiomas appear photopaenic on Gallium scintigraphy 
(Drane et al., 1987). Metastases are photopaenic in about 50% of cases, 
most of the remainder revealing uptake similar to normal liver tissue, while 
occasionally metastases, including malignant melanoma and diffuse 
histiocytic lymphoma, may demonstrate increased activity uptake (Drane et 
al., 1987). Most hepatomas have gallium uptake equal to or greater than that 
of adjacent liver tissue (Cornelius and Atterbury, 1984; Drane et al., 1987). 
Focal nodular hyperplasia may reveal isoactivity or hyperactivity but 
photopaenic lesions do occur, while the patterns of activity uptake in hepatic 
adenoma are variable and poorly studied (Drane et al., 1987). 
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INVESTIGATION WITH OTHER IMAGING MODALITIES 
Ultrasound (US) 
The increased availability of real-time ultrasound has led to increased 
detection of benign focal liver lesions, particularly hepatic haemangiomas 
(Lipman and Tumeh, 1990). The classic sonographic appearance of the liver 
haemangioma is that of a homogeneously hyperechoic lesion with a well-
defined and smooth margin (Birnbaum et al., 1990; Reading et al., 1988; 
Tumeh et al., 1987). Although this typical appearance is seen in 50 - 60% of 
cases and sensitivities of 83 - 100 % are reported, the specificity is relatively 
low (Sandler et al., 1981; Bree et al., 1983; Prakash et al., 1987). The 
differential diagnosis of solitary, homogeneous hyperechoic lesions includes 
metastases, hepatocellular carcinoma, hepatic adenoma and focal nodular 
hyperplasia (Bree et al., 1983; Birnbaum et al., 1990; Sandler et al., 1981; 
Green et al., 1977; Kamin and Bernadina 1979; Scheible and Gosink, 1977; 
Taylor et al., 1987). 
The echogenicity of hepatic cavernous haemangioma results from the 
multiple interfaces between the walls of the cavernous sinuses and the 
contained blood. Most haemangiomas measure less than 2 cm in diameter 
and in this size usually have a typical appearance. The internal architecture, 
however, differs in larger lesions and may be complicated by haemorrhage, 
thrombosis, myxomatous change, fibrosis and calcification (Lipman and 
Tumeh, 1990). These changes alter the sonographic pattern, producing 
variable echogenicitiy, hypoechoic and occasionally large anechoic areas, 
varying degrees of posterior acoustic enhancement attributed to variable 
vascularity, and acoustic shadows produced by foci of calcification (Birnbaum 
et al., 1990; Gillebert et al., 1980; Bruneton et al., 1983; Taboury et al., 1983; 
Prakash et al., 1987). 
The ultrasonographic appearance of cavernous haemangioma can be divided 
into three groups (Wiener and Parulekar 1979; Ohto et al., 1987): (i) 
hypoechoic; (ii) hyperechoic; and (iii) complex. A diagnosis of haemangioma 
can only be reliably entertained when a hyperechoic pattern is found, and 
because of the great variability of the sonographic appearance, ultrasound is 
not the modality of choice for the diagnosis of hepatic cavernous 
haemangioma (Mirk et al., 1982; Gandolfi et al., 1991; Rubin and 
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Lichtenstein, 1993). Pulsed doppler ultrasound may have advantages in the 
differentiation of haemangioma from hepatocellular carcinoma but does not 
enable distinction from metastases and has not yet been adequately 
evaluated (Taylor et al., 1987). 
Computer Tomography (CT) 
On incremental dynamic bolus CT, the appearance of small ( < 1 cm) foci of 
globular enhancement is suggestive of HCH, analagous to areas of contrast 
material puddling seen on angiography (and on dynamic contrast enhanced 
MRI), but sensitivity and specificity of this method still have to be determined 
(Quin and Benjamin, 1992). To meet the established diagnostic criteria for 
hepatic cavernous haemangioma, single level, dynamic bolus CT scanning is 
necessary, in which the liver is first scanned prior to contrast and then 
repeatedly on the same level after rapid bolus contrast administration. Freeny 
and Marks (1986a, 1986b) described a triad of morphological diagnostic 
criteria for the diagnosis of hepatic cavernous haemangioma: 
• Diminished attenuation on non-contrast enhanced scans (excluding 
lesions arising in a fatty liver); 
• Peripheral contrast enhancement during the bolus dynamic phase 
(using rapid intravenous administration of 150 ml of a 60% contrast 
medium); 
• Complete isodense fill-in on delayed scans obtained up to 60 min 
following contrast medium administration. 
Diminished attenuation on non-contrast scans is found in 96% of 
haemangiomas (Freeny and Marks, 1986a; Freeny and Marks, 1986b; Ashida 
et al., 1987). Haemangioma present in a liver with diffuse fatty infiltration may 
be isodense or even hyperdense on a pre-contrast scan (Freeny and Marks, 
1986a). Freeny et al. (1986a) reported peripheral contrast enhancement 
during the bolus dynamic phase in 7 4% of cases. This results from the high 
early arteriovenous attenuation difference (within the first two minutes 
following bolus contrast media administration), resulting in enhancement of 
the lesion periphery, while the lesion centre remains unenhanced; if more 
delayed scans are obtained, the pattern of enhancement may change from 
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peripheral to diffuse enhancement or to a mixed or heterogeneous pattern 
(Freeny and Marks 1986b). Freeny and Marks (1986a) found fill-in to be 
absent in 5 of 54 (9.3%) of cases, partial in 11 of 54 (20.4%) cases and 
complete in 38 of 54 (70.4%). 
Freeny et al. (1986a) found a pattern of peripheral contrast enhancement and 
complete isodense fill-in, in 54% of the haemangiomas in their study, while 
Freeny and Marks (1986b) found all three diagnostic criteria in 55% of the 
haemangiomas studied, indicating a significant loss of sensitivity. If more 
liberal criteria for the CT diagnosis of haemangioma had been used (such as 
central or mixed patterns of contrast enhancement or incomplete isodense 
fill-in with central clefts), the sensitivity certainly would have been increased 
but at the expense of a loss of specificity, resulting in metastases being 
diagnosed incorrectly as haemangiomas (Freeny and Marks, 1986a; Bree et 
al., 1987). Specificity is also hampered by the appearance of some 
hepatomas and metastases as hypodense lesions with centripetal contrast 
enhancement (Barnett et al., 1980; Burgener and Hamlin, 1983). 
Ashida et al. (1987) expanded the criteria to five, including progressive 
centripetal opacification, a delay of at least 3 minutes before total 
opacification, and isodense fill-in with or without non-opacified clefts. 79% of 
lesions fulfilled all five criteria, but if the data is applied to the classic (three 
criteria) model of Freeny and Marks, only 45% of the lesions would be 
diagnosed as cavernous haemangiomas (Lipman and Tumeh, 1990). 
Further complicating the CT diagnosis of haemangioma is the presence of 
central fibrosis, thrombosis and haemorrhage, which results in delayed or 
absent central opacification and the presence of non-enhancing central clefts 
in large haemangiomas (Johnson et al., 1981; Scatarige et al., 1987; Ashida 
et al., 1987). Small lesions may be difficult to study dynamically owing to 
respiratory artifact, while characterization of multiple lesions is tedious and 
could even be hazardous as safe dosages of contrast material may be 
exceeded (Farlow et al., 1990; Brodsky et al., 1987). 
Hepatic angiosarcoma can reveal findings similar to those of cavernous 
haemangioma on dynamic CT, angiography and MRI (ltai and Teraoka, 
1989). 
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In summary, rapid bolus contrast enhanced CT scans are less sensitive and 
specific than SPECT blood pool scintigraphy in the diagnosis of hepatic 
cavernous haemangiomas. The latter is also cheaper and easier to perform 
(especially when several lesions are present), and can be safely applied in 
patients with contrast agent intolerance and in hyperthyroid patients 
(Moinuddin et al., 1985; Front et al., 1984; Langsteger et al., 1989). 
Magnetic Resonance Imaging (MRI) 
MRI has emerged as an accurate and safe, though expensive method for the 
diagnosis of hepatic cavernous haemangioma (Stark et al., 1985). 
Haemangiomas classically appear as homogeneous lesions of high signal 
intensity on T2-weighted images (Wittenberg et al., 1988). Since fluids have 
a long T2 value and the haemangioma is essentially a lake of flowing blood, 
these lesions are more distinctive on long echo time (TE) T2-weighted 
sequences, and Stark et al. (1985), using a multi-echo technique, found a TE 
of 120 ms to yield the most useful images. However, all hepatic neoplasms 
become hyperintense relative to adjacent liver on T2-weighted images, so 
that it is the degree of hyperintensity (the so-called light bulb sign) that is 
characteristic of haemangioma (Ziessman et al., 1991; ltai et al., 1985). A 
mean T2 time greater than 80 m sec is reported to be characteristic of 
hepatic cavernous haemangioma, at both 0.35 and 1.5 Tesla field strength, 
and sensitivities of 83-90 % (specificities of 95-98 %) have been reported in 
series of patients based purely on T2-weighted properties ( ltai et al., 1985; 
Ohtomo et al., 1985; Ohtomo et al., 1988). In addition to haemangiomas 
being brighter than hepatocellular carcinoma on T2-weighted images, the 
signal intensity increase from T1 - to T2-weighted images is greater for 
haemangioma than for hepatocellular carcinoma (Ho et al., 1992). In addition 
to a long T2 value, the homogeneity and sharp margins of haemangioma on 
MRI images help to distinguish this lesion from malignant disease (Stark et 
al., 1985). However, inhomogeneity in haemangiomas produced by fibrosis, 
thrombosis and ossification, would result in a less typical appearance 
(decreased T2 value) while liquefaction or necrosis in a hepatoma could 
produce an image simulating a haemangioma (i.e. increased T2 value) (Ros 
et al., 1987). Hepatocellular carcinoma with dense acinar formation 
(pseudoglandular type) is associated with T2 prolongation based on the 
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abundant intra-acinar fluid, and this could render differentiation from 
haemangioma difficult (Ohtomo et al., 1990). 
Differentiation of haemangioma from certain hypervascular metastases, such 
as metastatic carcinoid, phaeochromocytoma, islet cell tumour, 
adenocarcinoma of the pancreas uterus and lung, and vascular sarcomas 
may be difficult, since they may also appear as homogeneous, hyperintense 
lesions on T2-weighted images (Wittenberg et al., 1988; Li et al., 1988; 
Birnbaum et al., 1990). Successful differentiation of haemangiomas from 
metastases may be possible utilizing T2 calculations with ultra fast MRI as 
opposed to conventional MRI T2-weighted imaging ( Goldberg et al., 1991; 
Lombardo et al., 1990). Successful differentiation may also be demonstrated 
with a combination of a dynamic MRI study and delayed post contrast T1 -
weighted imaging (Hamm et al., 1990). 
On MRI imaging with intravenous injection of gadolinium-DTPA, 
haemangiomas are characterised by a hypointense appearance before 
injection, followed by peripheral intensity enhancement after injection and by 
subsequent progressive hyperintense fill-in and hyperintensity in the late 
phase; it is suggested that dynamic contrast enhanced MRI is an effective 
method to facilitate the differential diagnosis when pre-contrast T2 weighted 
images are equivocal (Olivetti et al., 1992; Ho et al., 1992; Murakami et al., 
1992). 
MRI imaging has a greater sensitivity than 99mTc blood pool SPECT with a 
slightly greater overall accuracy, particularly in the detection of 
haemangiomas smaller than 2 cm in diameter and in the detection of 
haemangiomas smaller than 2.5 cm that are adjacent to the heart or major 
intrahepatic blood vessels (Birnbaum et al., 1990; ltai et al., 1985). The 
specificity of MRI for haemangiomas is thought to be good, despite the 
inability to categorically differentiate haemangiomas from hypervascular 
metastases. The main contraindication to its wide use, is the high cost, and 
SPECT may be useful in the diagnosis of haemangiomas larger than 2 to 2.5 
cm in diameter (Birnbaum et al., 1990; Li et al., 1988). MRI may serve as a 
complementary technique for the non-invasive characterization of 
haemangiomas demonstrating an atypical scintigraphic appearance and 
considered to be indeterminate (Birnbaum et al., 1990). 
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Angiography 
Traditionally considered the gold standard, angiography is both sensitive and 
specific for the diagnosis of hepatic cavernous haemangioma, but is an 
invasive procedure and requires the use of contrast materials (Johnson et al., 
1981 ). With the availability of accurate non-invasive modalities, there is a 
limited role for angiography in the evaluation of liver cavernous 
haemangioma, reserved for diagnostically equivocal cases and for 
preoperative assessment where it provides vital hepatic vascular anatomic 
information (Bornman et al., 1987). 
The classic angiographic appearance of haemangioma (Freeny et al., 1979; 
Freeny, 1983; Mcloughlin, 1971) includes: 
• The main hepatic artery and its branches are of normal calibre, but 
may be displaced to one side and crowded together. 
• The feeding vessels are of normal calibre and taper normally to form 
a fine vascular network within the haemangioma, but the individual 
vessels have a normal appearance 
• Arteriovenous shunts and draining veins are rare and there is no 
tumour neovascularity 
• During the early arterial phase, small lakes of contrast media 
accumulate around the periphery of the lesion, forming a C- or ring-
shaped configuration. 
• The contrast material in the vascular spaces persists throughout the 
capillary and late venous phases. 
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Atypical angiographic features may be encountered in liver haemangiomas: 
• Arterioportal shunting, usually an angiographic finding 
pathognomonic of malignancy and commonly present in 
angiosarcoma. However this may occasionally be present in 
haemangioma (Ando et al., 1984; Winograd and Pulabinskas, 1977; 
Weiler et al., 1992; Shima et al., 1989); 
• Diffuse intense contrast enhancement may be present (Mikulis et al., 
1985). 
Angiography may occasionally be normal even in the presence of 
symptomatic haemangioma, and lesions in the left lobe overlying the spine 
may be difficult to visualize on angiography (Davis et al., 1990; Bornman et 
al., 1987). Selective left hepatic arteriography, although requiring special 
expertise in technique and interpretation, or intra-arterial digital subtraction, 
may be of value in the evaluation of lesions in the left lobe (Flauniger et al., 
1983). 
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NON-IMAGING INVESTIGATIVE MODALITIES 
Biopsy 
Biopsy of hepatic cavernous haemangioma and haemangioendothelioma with 
needles of outside diameter greater than 1 mm is associated with a relatively 
high risk of serious or even fatal haemorrhage (Kato et al., 1975; Zamcheck 
and Klausenstock 1953; Haaga and Vane, 1979; Walt 1977; Karpas and 
Pavon, 1971 ). As a result, biopsy of hepatic cavernous haemangioma with 
large bore needles is contraindicated (Solbiati et al., 1985). 
In contrast biopsy of liver cavernous haemangioma with fine needles of 
outside diameter less than 1 mm under ultrasonographic guidance, has 
shown adequate results with no significant risk to the patient, provided that 
subcapsular lesions are biopsied through interposed liver tissue and not by a 
direct route (Spamer et al., 1986; Solbiati et al., 1985; Taavitsainen and 
Kivisaari, 1987; Cronau et al., 1988; Bree et al., 1983; van Sonnenberg et al., 
1981 ). Terriff et al. (1990), however, reported a fatality following fine needle 
aspiration biopsy of a hepatic cavernous haemangioma. 
The criteria to establish a diagnosis of liver cavernous haemangioma are the 
aspiration of fresh blood and endothelial cells and/or agglomerates of 
capillaries (Solbiati et al., 1985; Bree et al., 1983). However, fine needle 
aspiration biopsy lacks specificity and biopsies of other malignant vascular 
tumours such as haemangiosarcoma and hepatocellular carcinoma, with 
histology mimicking cavernous haemangioma, have been documented 
(Bornman et al., 1987). Fine needle aspiration biopsy is said to have a high 
accuracy in some hands ( Cronau et al., 1988; Xu, 1989; Kaw and Esparza, 
1991; Nakaizumi et al., 1990). 
Laparoscopy 
Laparoscopy may be useful in the diagnosis of haemangioma when the lesion 
is subcapsular, especially in the presence of a palpable mass. Although this 
may prove useful in selected cases, the depth and extent cannot be 
determined, and the presence of fibrosis and/or necrosis in the haemangioma 





The asymptomatic incidentally discovered cavernous haemangioma can 
safely be observed with serial studies as long as the lesion is small ( < 2 cm in 
diameter) and the diagnosis of HCH is reasonably certain. The risk of 
unmanageable growth and spontaneous haemorrhage is small compared with 
the low but significant morbidity and potential mortality attendant a 
prophylactic resection ( lwatzuki et al., 1990; Starzl et al., 1980; Reading et 
al., 1988; Trastek et al., 1983; Andersson and Bengmark, 1988; Schwartz and 
Husser, 1987; Adam et al., 1970; Trastek et al., 1983). Alteration of the 
character or size of the lesion requires thorough reinvestigation with 
appropriate reassessment of the management strategy ( lwatzuki et al., 1990; 
Starzl et al., 1980). Alternatively, in the presence of an equivocal diagnosis, 
hepatic resection may be indicated as the risk of missed diagnosis of cancer 
should not be underestimated (Lise et al., 1992; lwatzuki et al., 1990; Starzl 
et al., 1980). This finding supports our contention that studies of the 
specificity of scintigraphy have been inadequate. Resection should also be 
considered in asymptomatic cases at diagnostic laparotomy, provided that 
the haemangioma location is amenable to resection with minimal risk, but 
asymptomatic lesions requiring major surgery should be treated expectantly 
(Bornman et al., 1987). 
Symptomatic and/or large haemangiomas 
Large haemangiomas (larger than 4 cm in diameter) may be considered for 
resection in some individuals, even when asymptomatic, owing to the 
increased incidence of central necrosis, acute haemorrhage into the lesion 
and possible rupture, either spontaneous or induced by blunt abdominal 
trauma (Reading et al., 1988; Vishnevsky et al., 1991; Riesener et al., 1990a; 
Nichols et al., 1989; Kanazawa et al., 1990). Large symptomatic 
haemangiomas are treated effectively and safely by excisional therapy, with 
relief of symptoms in the majority of cases, a low operative morbidity and a 
zero operative mortality rate for elective surgery (Starzl et al., 1980; lwatzuki 
et al., 1990; Schwartz and Husser, 1987; Adam et al., 1970; Kawarada and 
Mizumoto, 1984; Yamagata et al., 1991; Riesener et al., 1990b). Thus, the 
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majority of patients with symptomatic and complicated haemangiomas are 
treated with hepatic resection, except when a significant risk is present due to 
difficult anatomic location, or systemic disease, where continued conservative 
treatment is appropriate (Bornman et al., 1987; Starzl et al., 1980). During 
formal lobar or segmental resection, the intraoperative blood loss can be 
extensive and it is essential that major vessels entering or leaving the 
specimen are controlled before the parenchymal resection is begun (Starzl et 
al., 1980; Schwartz and Husser, 1987). 
An alternative to resection is enucleation through dissection along the fibrous 
capsule or compressed adjacent parenchyma, with direct control of blood 
vessels entering or leaving the haemangioma and without resection of normal 
adjacent liver parenchyma (Alper et al., 1988; Adson, 1986). 
Hepatic arterial embolization may improve symptoms, but rarely reduces the 
size or subsequent vascularity of the haemangioma; and may be associated 
with necrosis and secondary infection of the lesion (Allison et al., 1985; 
Reading et al., 1988; Bornman et al., 1987; Trastek et al., 1983). Hepatic 
arterial ligation may similarly reduce symptoms, but precludes future 
embolization should revascularisation of the haemangioma cause a 
recurrence of symptoms (Nishida et al., 1988; Reading et al., 1988). Both 
hepatic arterial embolization and ligation may control acute bleeding 
(Yamamoto et al., 1991) and give symptomatic relief, but these procedures 
should be reserved for selected cases (Hobbs, 1990). 
Radiotherapy has historically been used in the management of non-
resectable haemangioma of the liver (Park and Phillips, 1970, McKay et al., 
1989), but the lack of objective evidence of benefit and the risks of radiation 
hepatitis, have largely precluded its further use (Trastek et al., 1983; Reading 
et al., 1988). 
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Chapter 2 
PATIENTS, MATERIALS AND METHODS 
PRIMARY AIM 
To assess the specificity of 99mTc labelled erythrocyte blood pool scintigraphy 
(incorporating radionuclide angiography, planar and SPECT imaging) in the 
diagnosis of hepatic cavernous haemangiomas by including adequate 
numbers of control patients with hepatic mass lesions not due to HCH. 
SECONDARY AIMS 
1. To establish the sensitivity of planar and SPECT imaging in the 
diagnosis of HCH at Groote Schuur Hospital. 
2. To describe the appearances of hepatic mass lesions on Technetium 
labelled erythrocyte scintigraphy. 
3. To establish if SPECT provides additional information over planar 
imaging in the investigation of hepatic mass lesions. 
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STUDY DESIGN 
Forty five patients (21 male, 24 female), aged 21 to 75 years (mean 54 years) 
presenting to the liver and hepatobiliary clinics at the Groote Schuur Hospital 
between January 1991 and December 1992, were prospectively studied 
following demonstration of solitary or multiple focal hepatic mass lesions 
(excluding hydatid cysts) on ultrasonography and/or computed tomography. 
Patients were fully prospectively evaluated by clinical and radiological 
investigations, including various combinations of magnetic resonance 
imaging, contrast enhanced bolus CT scans, angiography, aspiration 
cytology and/or biopsy or surgical resection. All patients also underwent 
hepatic 99mTc erythrocyte scintigraphy. 
Final diagnosis 
All patients had a diagnosis based on clinical and non-scintigraphic studies to 
avoid introducing bias in the case of positive scintigraphic studies. The final 
clinical diagnosis was used as the reference against which the results of 
scintigraphy were compared. 
The usual process followed to establish the diagnosis was evaluation of 
clinical, biochemical and ultrasonographic data, followed by the evaluation of 
the radiological data excluding the scintigraphic data and thereafter by the 
evaluation of follow-up and histological data. 
The diagnosis of the hepatic mass lesion based on these criteria was then 
compared to the diagnosis made by scintigraphy. 
Scintigraphic data was evaluated separately by three observers; two were 
blinded to clinical and other data. Inter-observer variation was established to 
determine the accuracy of the observations. 
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Erythrocyte labelling 
The labelling of autologous erythrocytes was performed with 900 MBq of 
00mTc pertechnetate by an in vitro technique: 
1. A vial of stannous pyrophosphate containing 1,092 mg of SnCl2 and 59,4 
mg of Na4P 20 7 (Atomic Energy Corporation, SA) was reconstituted at 
room temperature with 10 ml 0. 9% sodium chloride solution BP; 
2. 1 ml of the reconstituted stannous pyrophosphate solution was diluted in 
9 ml of 0.9% sodium chloride solution BP to make up 10 ml; 
3. 0.5 ml of the reconstituted diluted stannous pyrophosphate solution was 
aspirated into a heparinized 20 ml syringe; 
4. 1 O ml of blood from the patient was then aspirated into this pre-prepared 
20 ml syringe; 
5. Pre-tinning and centrifugation: 
(a) The blood-heparin-stannous-pyrophosphate mixture was injected into 
a sterile vial; and 
(b) incubated for 5 min at room temperature while being gently agitated; 
(c) 1 ml of 4.4% EDTA1 solution was injected into the vial which was 
gently agitated for 30 seconds; 
( d) then centrifuged for 5 min at 2000 rpm; 
(e) Two millilitres of packed red blood cells were then aspirated from the 
vial; and 
(f) transferred into a sterile vial containing approximately 1200 MBq 99mTc 
pertechnetate; 
(g) This mixture was incubated at room temperature for 1 O min while being 
gently agitated; 
(h) 900 MBq 99mTc labelled red blood cells were then reinjected into the 
patient. 
1 EDTA chelates extracellular free stannous ions, thereby preventing reduction of 
pertechnetate before it penetrates the erythrocyte membrane (preventing formation of 
radionuclidic impurities such as Sn:Tc colloid and/or labelled plasma proteins), resulting in 
improvement of the labelling yield and the in vitro and in vivo stability of the label (Mock 
and Wellman, 1984; Srivastava and Chervu, 1984) 
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Radionuclide imaging system 
Dynamic, planar and SPECT imaging were performed on the same system 
(General Electric Starcam 400 AC) consisting of a rotating single head, large 
field of view (40 cm) Anger camera, equipped with a low energy high 
resolution parallel-hole collimator. Planar imaging was performed on all 45 
patients while SPECT imaging was performed on 41. 
Acquisition technique 
1. Radionuclide angiography was performed with a framing rate of one 
frame per second for 90 seconds on a 64 x 64 acquisition matrix in the 
most appropriate projection, based upon ultrasonographic or CT lesion 
localization. 
2. Planar imaging was performed on a 256 x 256 acquisition matrix with 
acquisition preset for 1 '000'000 counts per image. 
a) Anterior and right lateral images were acquired immediately following 
the dynamic phase. 
(i) When a lesion was visible on the initial images, an image was 
acquired in the projection of best visualization (anterior or right 
lateral) at 7 min post-injection. Thereafter, images were acquired in 
the anterior, right lateral and posterior projections at 10, 20 and 30 
min post-injection. 
(ii) When a lesion was not visible on the initial images, images were 
acquired in the anterior and right lateral projections at 5 min intervals, 
starting at 1 O min post-injection and continuing until 30 min post-
injection. If a lesion became visible during this imaging interval, the 
imaging protocol reverted to that described under (i). 
b) Images in the anterior, right lateral and posterior projections were 
acquired at 2 hours post-injection. 
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3. SPECT was performed at two hours post injection, immediately following 
acquisition of the two hour planar images. Data was acquired on a 64 x 
64 matrix in 64 angular projections over a 360° elliptical rotation, in step 
and shoot mode, with the patients arms raised above the head. The 
optimal image projection interval was determined for each patient 
individually as the time required to reach a mean pixel count of between 
180 and 200 in the liver on the anterior projection image. 
DATA PROCESSING 
1. Summation of the 1 sec/frame dynamic acquisition data to 3 sec/frame 
images. 
2. Reconstruction of SPECT data by an integrated computer system, using 
software provided by the manufacturer and utilizing a filtered back 
projection technique. Transverse sections, with a thickness of 1 pixel 
(0.63 mm) were obtained first and sagittal and coronal section one pixel 
thick were obtained subsequently. 
3. The study was prefiltered using a Hanning filter with a critical frequency 
of 0,8 cm-1 and it was filtered using a back projection ramp filter with a 
critical frequency of 0,0 cm-1. 
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IMAGE ANALYSIS AND INTERPRETATION 
Scintigraphic image analysis and interpretation ( dynamic three view computer 
display) were performed at the time of investigation by observer 1 (SL) with 
knowledge of the clinical data and lesion location. Analysis and interpretation 
( dynamic three view computer display) were performed by observers 2 and 3 
at a second stage without knowledge of clinical data, lesion location or final 
diagnosis. 
Criteria for the diagnosis of hepatic cavernous haemangioma: 
1. Activity in the lesion must be increased relative to the adjacent hepatic 
parenchyma on the planar and/or SPECT images in the late blood pool 
phase (at 2 hours post injection); 
and; 
2. Activity in the lesion must have increased or remained constant relative 
to the adjacent hepatic parenchyma from the dynamic to the late blood 
pool phase. 
Categorization of cavernous haemangiomas according to 
scintigraphic appearance: 
A study was categorized as having a characteristic appearance, if the lesion's 
activity increased relative to adjacent hepatic parenchyma in the late blood 
pool phase, with or without progressive increase of intensity from early to late 
blood pool phases. If, in addition, the lesion's activity was decreased relative 
to adjacent parenchyma in the dynamic phase (early post injection), the study 
was categorized as being characteristic and typical. If the less common 
feature of increased lesional activity in the dynamic phase was present, the 
study was classified as characteristic but atypical. 
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STATISTICAL ANALYSIS OF SCINTIGRAPHIC RESULTS 
True positives were defined as scintigraphic tests in which the scintigraphic 
studies correctly diagnosed HCH as confirmed by other clinical, radiological 
and histological studies. 
True negative tests were defined as those tests where scintigraphic data 
correctly identified a lesion as not being HCH. 
False positive tests were defined as those where the scintigraphic data 
incorrectly identified a lesion as being HCH, but where other clinical, 
radiological and histological data definitively characterised the lesion as not 
being HCH. 
False negatives were defined as tests where scintigraphic data incorrectly 
identified a lesion as not being a haemangioma, but where other data showed 
the lesion to be an haemangioma. 
Reproducibility of scintigraphic analysis was assessed by measuring inter-
observer variability. Each study was interpreted by three observers, two of 
whom were blinded to all clinical and other radiological data. Inter-observer 





Forty-five patients (21 male), mean age 54 (range 21-75), presenting with 
focal hepatic mass lesions (HML) were studied. 
Of the 45 patients, the final diagnosis was indeterminate in 8, and these 
patients were excluded from the statistical analysis. Of the remaining 37 
patients, clinically 30 haemangiomas were found in 18 patients, while 37 non-
haemangiomatous lesions (20 metastatic carcinoma, 11 primary 
hepatocellular carcinoma, 3 focal nodular hyperplasia, 2 probably malignant 
liver neoplasms and 1 chronic hepatic abscess), were diagnosed in 19 
patients. 
Of the 17 patients with HCH who underwent ultrasonography, hyperechoic 
lesions (typical for HCH) were found in 13 patients (76%), hypoechoic lesions 
in 1 and complex lesions in 3. 
Of the 14 patients with a final diagnosis of HCH who underwent dynamic CT, 
8 patients had lesions compatible with HCH, 5 patients had lesions 
characteristic of HCH, while 1 patient had a lesion not typical of HCH. All 
lesions in these 14 patients were low density on CT. 
MRI was performed in only one patient (final diagnosis of HCH), and revealed 
features compatible with HCH. 
Of the 6 patients who underwent angiography, 1 patient (final diagnosis HCH) 
revealed features compatible with haemangioma. 
HCH was diagnosed by histology in 3 patients (1 by liver biopsy, 2 by 
resection), whereas in one patient with an initial clinical diagnosis of HCH, 
liver biopsy revealed features of a lymphangioma. 
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The control group consisted of 19 patients (Appendix 25). 
Eight patients had metastatic liver disease [1 adenocarcinoma breast, 1 
adenocarcinoma colon, 1 adenocarcinoma of undetermined origin, 1 
carcinoma bronchus, 1 poorly differentiated carcinoma (? melanoma), 1 
transitional cell carcinoma, 1 sarcoma, 1 spindle cell tumour 
(?leiomyosarcoma)]. Seven patients had hepatocellular carcinoma, 1 had a 
(benign) liver neoplasm, 2 had focal nodular hyperplasia and 1 had a liver 
abscess. 
Of the six patients undergoing angiography, features compatible with focal 
nodular hyperplasia were found in 1 patient, neovascularity in 2 patients (final 
diagnosis hepatocellular carcinoma), and hypervascularity in 1 patient (final 
diagnosis of hepatocellular carcinoma). 
Of the 12 patients from the control group undergoing liver aspiration cytology, 
no malignant cells were found in 3 patients, highly atypical cells were found 
in 1 (final diagnosis low grade malignancy/HCC), malignant cells compatible 
with HCC in 3, metastatic carcinoma in 3, metastatic sarcoma in 1 and 
inflammatory cells compatible with abscess in 1 patient. Liver biopsy was 
obtained in two patients in the control group, both revealing HCC. 
SCINTIGRAPHY 
Basic analysis of scintigraphic features (observers I, II, Ill) 
Observer I found 25 haemangiomatous lesions in 18 patients. Observer II 
found 24 haemangiomatous lesions in 17 patients, and observer Ill found 18 
haemangiomatous lesions in 14 patients. Scintigraphic features typical of 
HCH were found in 7 patients with hepatic malignancy by observer I (5 
hepatocellular carcinomas, 2 metastatic carcinomas), in 6 of these 7 patients 
by observer II, in 2 patients of these 7 patients by observer Ill (Tables 1,3). In 
addition, scintigraphic features characteristic of HCH were found in 1 patient 
with hepatic abscess (false positive prominent portal vein activity) by 
observer II and in 1 patient with metastatic sarcoma by observer Ill (Table 3). 
Five of the 7 false positive cases had histological or cytological confirmation 
of the diagnosis, the diagnosis in the remaining two established on clinical 
and biochemical (alpha fetoprotein) grounds. 
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TABLE 1. Sensitivity, specificity and diagnostic accuracy of 
scintigraphy for HCH, according to 3 observers. 
STATISTICAL Observer Observer Observer 
ANALYSIS I II Ill 
True positive (TP) 18 17 14 
True negative (TN) 12 12 16 
False positive (FP) 7 7 3 
False negative (FN) 0 1 4 
Specificity / true negative ratio TN/(TN+FP) 0.632 0.632 0.842 
Sensitivity / true positive ratio TP/(TP+FN) 1.000 0.944 0.778 
Positive predictive value TP/(TP+FP) 0.720 0.708 0.824 
Negative predictive value TN/(TN+FN) 1.000 0.923 0.800 
False positive ratio (1-specificity) FP/(TN+FP) 0.368 0.368 0.158 
False negative ratio (1- FN/(TP+FN) 0.000 0.056 0.222 
sensitivity) 
Accuracy (TP+ TN)/(TP+FP+FN+ TN) 0.811 0.784 0.811 
Disease prevalence (TP+FN)/(TP+ TN+FP+FN) 0.486 0.486 0.486 
TABLE 2. Inter-observer variation 
INTEROBSERVER Fischer Test Mantel-Haenzel Contingency 
VARIATION Chi-Square Test Coefficient 
Observer 1-11 p=1.000 p=0.861 0.117 
Observer 1-111 p=0.084 p=0.175 0.288 
Observer 11-111 p=0.267 p=0.233 0.240 
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False positive results 
The right hand column indicates the total number of patients incorrectly 
diagnosed by any one of the three observers and the bottom column the total 
number by each individual observer. 
TABLE 3. Lesions diagnosed incorrectly as HCH, by 3 independent 
observers. 
FALSE POSITIVES I II Ill TOTAL 
Hepatocellular carcinoma 5 5 2 5 
Metastatic carcinoma 2 1 - 2 
Liver abscess - 1 - 1 
Metastatic sarcoma - - 1 1 
TOTAL 7 7 3 
Detailed analysis of scintigraphic features (observer I) 
All of the 25 haemangiomatous lesions demonstrated scintigraphically 
revealed increased activity in the lesion relative to the adjacent hepatic 
parenchyma in the late blood pool phase, at 1-2 hours p. i. The scintigraphic 
features of the true and false positive lesions in the dynamic phase are 
presented in Table 4. In 14 lesions, the dynamic phase revealed normal flow. 
Activity was decreased in the lesion relative to adjacent hepatic parenchyma 
in 2 lesions and increased relative to adjacent parenchyma in 5 lesions, in 
the dynamic phase. A mixed pattern was present as a small area of increased 
flow either contained within, or situated adjacent to and contiguous with a 
large area of decreased flow, in 4 lesions. Only one patient with cavernous 
haemangioma (patient 26) showed peripheral-centripetal filling-in the 
dynamic phase. In this patient, activity surrounding a large photopaenic area 
in the right lobe, appeared within 3 seconds of aortic activity and was 
followed by progressive centripetal fill-in of the greater part of the cold area in 
the late blood pool phase. All 11 mass lesions in the 5 patients with 
hepatocellular carcinoma, and all 4 mass lesions in the 2 patients with 
metastatic disease, which were interpreted as being false positive for HCH, 
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demonstrated increased activity in the lesion relative to the adjacent hepatic 
parenchyma in the late blood pool phase. Eight of the 11 hepatocellular 
carcinoma lesions demonstrated increased perfusion in the dynamic phase. 
TABLE 4. Scintigraphic features of the true and false positive lesions in 
the dynamic phase 
TRUE Decreased TOTAL NUMBER 
AND and NUMBER OF 
FALSE Normal Decreased Increased Increased OF PATIENTS 
POSITIVES LESIONS 
Perfusion Perfusion Perfusion Perfusion 
Cavernous 14 2 5 4 25 
haemangioma 
Hepatocellular 3 - 8 - 11 
carcinoma 
Metastatic 4 - - - 4 
carcinoma 
The scintigraphic patterns of the true negative lesions are presented in Table 
5. In the 12 patients of the control group with lesions true negative for 
haemangioma, 4 patients had normal flow and normal blood pool (1 HCC, 2 
metastatic carcinoma, 1 liver neoplasm), 1 patient had normal flow and 
decreased blood pool (metastatic carcinoma), 6 patients had decreased flow 
and decreased blood pool (1 HCC, 1 metastatic carcinoma, 1 metastatic 
sarcoma, 1 metastatic spindle cell tumour, 1 abscess, 1 low grade 
malignancy/FNH) and 1 patient had increased flow and decreased blood pool 
(FNH). The lesion in one patient (patient 4, final diagnosis of focal nodular 
hyperplasia), displayed a transient arterial activity blush in the very early 
dynamic phase, with activity increased relative to adjacent parenchyma, 
appearing within 5 seconds of aortic activity and becoming isoactive with 
adjacent parenchymal activity 1 O seconds following aortic activity 
appearance. The planar static images revealed a rounded cold focus 


























































































































































































































































































































































































































































































































































































































































































































The number of lesions demonstrated scintigraphically is presented in Table 
6. Twelve patients had solitary haemangiomas while 6 had two 
haemangiomas. In the control group, solitary lesions were found in 1 O 
patients, two lesions in 2 and more than two lesions in 3, while no lesion was 
detectable scintigraphically in 4. 
TABLE 6. Scintigraphic lesion number 
LESION NUMBER Patients Patients Patients Patients TOTAL TOTAL 
with with with with NUMBER NUMBER 
no solitary two ###two LESIONS PATIENTS 
detectable lesions lesions lesions 
lesions 
Haemangioma group - 12 6 - 25 
Non-haemangioma 4 10 2 3 23 
group 
Indeterminate group 5 1 1 1 7 
Entire group 9 23 9 4 56 
The location of lesions demonstrated scintigraphically is presented in Table 
9. The greater majority of haemangiomas were present in the right lobe (20), 
whereas lesions in the left lobe totalled only 5. In the control group, the same 
tendency was found, with 20 lesions present in the right lobe (although 3 of 
these lesions revealed extension into the medial segment of the left lobe), 
and 3 lesions in the left lobe. 





LESION LOCATION Patients Lesions in Lesions in Lesions in TOTAL TOTAL 
with (R) lobe (L) lobe (L) lobe NUMBER NUMBER 
lesions in medial lateral LESIONS PATIENTS 
both lobes segment segment 
Haemangioma group 3 20 4 1 25 18 
Non-haemangioma 3 20 3 - 23 19 
group 
Indeterminate group - 5 2 - 7 8 
Entire group 6 45 9 1 56 45 
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Planar imaging was performed in all 45 patients, SPECT in 41. The results of 
the comparison between planar versus SPECT imaging obtained from the 
subgroup where both planar and SPECT imaging were performed, is detailed 
in Table 8. All 8 cold areas were detected by both modalities. SPECT 
detected 42 foci of increased activity as opposed to 33 detected by planar 
imaging. In the haemangioma subgroup, SPECT detected 22, planar imaging 
21, while in the non-haemangioma subgroup, SPECT detected 13, planar 
imaging 10. The differences are not statistically significant (Fischer test, 
p=O. 801). In the haemangioma group, four small lesions were seen with 
greater clarity on the SPECT images and in one patient with an indeterminate 
final diagnosis, four small hot foci were only visible on the SPECT images. 
TABLE 8. Planar versus SPECT imaging 




Entire Group 8 8 41 
HOT FOCI: 
Haemangioma group 21 22 16 
Non-haemangioma group 10 13 17 
Indeterminate group 2 7 8 
Entire group 33 42 41 
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CASE REPORTS (FALSE POSITIVE LESIONS) 
A. Hepatocellular carcinoma 
Five patients with hepatocellular carcinoma were misdiagnosed as having 
cavernous haemangioma (Table 7). 
Case 1 (patient 17) presented with a history of alcoholism, loss of weight, 
right upper quadrant pain and massive hepatomegaly. The AST and ALT 
were 2x normal and the alpha fetoprotein was > 100 ng/ml (normal = 10 
ng/ml). Ultrasonography revealed a single well defined partially 
encapsulated lesion of mixed echogenicity (complex pattern) 11 cm in 
diameter, in the right lobe. CT revealed a 15 x 12 cm lesion of mixed 
density in the right lobe; the dynamic contrast enhanced study was not 
typical of cavernous haemangioma. Angiography revealed a large 
hypervascular lesion in the right lobe with bizarre, irregular internal 
vascularity and neovascularity. Cytology of the liver aspirate 
demonstrated malignant cells. A diagnosis of hepatocellular carcinoma 
was made. Scintigraphy demonstrated increased activity in the dynamic 
phase and in the late blood pool phase. The focal increased activity was 
present in the superolateral part of the right lobe in the dynamic phase, 
the activity increasing in intensity over time in the planar images and 
confirmed in the SPECT images. The activity in the adjacent hepatic 
parenchyma was inhomogeneous. 
Case 2 (patient 18) presented with loss of weight, abdominal pain and 
ascites with a nodular firm and tender hepatomegaly extending 6 cm 
below the costal margin. The alpha fetoprotein was > 1000 ng/ml. A 
diagnosis of HCC was made. Scintigraphy demonstrated increased 
activity in the late blood pool phase. The perfusion phase revealed an 
area of increased activity in the inferior part of the right lobe and the 
medial segment of the left lobe, appearing in the mid to late perfusion 
phase. In the planar images, areas of activity increased relative to the 
adjacent parenchymal activity were seen as two contiguous foci inferiorly 
and one inferolaterally in the right lobe and one focus in the medial 
segment of the left lobe. The activity in these foci increased slightly in the 
early blood pool phase but then remained constant into the late phase. 
The foci were confirmed in the SPECT images. 99mTc sulphur colloid 
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scintigraphy revealed multiple photopaenic areas in both lobes. A large, 
rounded, partially photopaenic area was present in the medial segment of 
the left lobe, encroaching upon the medial part of the right lobe. 
Increased activity was present in the rim of this area, superiorly (diffuse) 
and inferiorly (as two focal areas, one inferomedially in the medial part of 
right lobe and one inferiorly in the medial segment of the left lobe). 
Further photopaenic areas were present in the right lobe superiorly, 
posteriorly and laterally. 
Case 3 (patient 28) presented with a history of alcoholism, marked weight 
loss over 6 months and right upper quadrant pain with a hard nodular 
hepatomegaly extending 20 cm below the costal margin. A bruit was 
present over the liver. The liver function tests were abnormal and the 
alpha fetoprotein > 85 ng/ml. Ultrasonography demonstrated an enlarged 
inhomogeneous liver with cystic and/or necrotic areas in the right lobe. 
Cytology of the liver aspirate revealed malignant cells compatible with 
hepatocellular carcinoma. Scintigraphy demonstrated focal increased 
activity in the inferior part of the right lobe in the early dynamic phase 
with subsequent persistence of increased activity throughout the planar 
images into the late blood pool phase. The SPECT images revealed an 
area of irregular increased activity (with an appearance of 3 contiguous 
foci) surrounding a central cold area, situated in the anteroinferior part of 
the right lobe. Activity throughout the remainder of the right lobe was 
inhomogeneous. 99mTc sulphur colloid scintigraphy revealed irregular 
photopaenia in the anteroinferior part of the right lobe laterally and in the 
superolateral part. 
Case 4 (patient 29) presented with sudden onset right upper quadrant 
pain after 3 days of heavy alcohol drinking and was in a state of 
hypovolaemic shock on admission to hospital. A three cm firm 
hepatomegaly was present on examination. The liver function tests and 
alpha fetoprotein were normal. Ultrasonography revealed a lesion of 
mixed echogenicity (complex pattern) in the right lobe posterior segment, 
9 x 8 x 6 cm in diameter. Two satellite lesions were observed in the right 
lobe anterior segment. The CT demonstrated a low density lesion in the 
inferomedial part of the right lobe which revealed increased size in a 
second study one month later. Angiography displayed a hypervascular 
lesion in the posterior segment of the right lobe, a second lesion in the 
68 
anterior segment of the right lobe and an obstructed right portal vein 
branch. Histology of the liver biopsy confirmed hepatocellular carcinoma. 
Scintigraphy, in the early dynamic phase in the posterior projection, 
demonstrated focal increased activity in the posterior segment of the liver 
superomedial to the right kidney, relative to the activity in the remainder 
of this segment. This increased activity subsequently persisted 
unchanged into the blood pool phase. Focal increased activity was also 
present anteroinferiorally in the right lobe, on anterior and lateral 
projections, relative to activity in the part of the right lobe medial to a 
large cold area situated superolaterally (subcapsular haematoma on CT 
imaging). Foci were confirmed on the SPECT study. 
Case 5 (patient 31) presented clinically with right upper quadrant pain, 
progressive abdominal distension and ascites, with a firm hepatomegaly 
extending 5 cm below the costal margin. The liver function tests were 
abnormal and the alpha fetoprotein was > 1000 ng/ml.. Ultrasonography 
revealed an inhomogeneous right lobe and multiple hyperechoic lesions 
with hypoechoic halos in the left lobe. Cytology of the liver aspirate 
revealed malignant cells compatible with an hepatocellular carcinoma. 
Scintigraphy demonstrated focal increased activity relative to adjacent 
parenchyma in the upper part of the right lobe anterolaterally and in the 
medial segment of the left lobe, appearing constant in early and late 
blood pool phases. The activity in the adjacent hepatic parenchyma was 
inhomogeneous. 
B. Metastatic carcinoma 
Two patients with metastatic carcinoma were misdiagnosed as having 
cavernous haemangioma (Table 7). 
Case 6 (patient 3) presented with a history of alcoholism and weight loss, 
with a smooth non-tender hepatomegaly extending 3 cm below the costal 
margin. Ultrasonography revealed multiple hyperechoic lesions (up to 2 
cm in diameter) throughout the liver. Histology of transbronchial biopsy 
material demonstrated bronchial carcinoma, but cytology of the liver 
aspirate revealed no malignant cells. A diagnosis of bronchial carcinoma 
with probable hepatic metastases was made. Scintigraphy demonstrated 
69 
a small focus of increased activity in the inferior tip of the right lobe in the 
early blood pool phase, which increased in intensity in the late phase. 
Case 7 (patient 45) presented with jaundice and abnormal liver function 
tests. Ultrasonography revealed a lesion 7 x 8.8 cm in diameter in the 
porta hepatis region. CT demonstrated a low density lesion in the porta 
hepatis lesion with irregular peripheral contrast enhancement. Cytology 
of the liver aspirate revealed cells compatible with metastatic 
adenocarcinoma. Scintigraphy, in the dynamic phase, demonstrated an 
ovoid ring of increased activity surrounding a cold area in the right lobe, 
appearing simultaneously with aortic activity and subsequently rapidly 
becoming isoactive with adjacent hepatic parenchyma, the central 
photopaenia persisting. On the SPECT images, a large photopaenic area 
was situated in the superomedial part of the right lobe with 3 foci of 
increased activity located in the periphery of this area (inferior, postero-
superior and postero-inferior). The inferior focus was seen in the early 
and late blood pool phases of the planar images, remaining constant in 
intensity. 
C. Liver abscess 
Case 7 (patient 36) presented with a history of pyrexial illness and 
abdominal pain. A non-tender smooth hepatomegaly was found on 
examination. The liver function tests were abnormal. Ultrasonography 
revealed a single 6 cm diameter hyperechoic lesion with an echolucent 
rim, in the right lobe. Cytology of the liver aspirate revealed the presence 
of inflammatory cells consistent with abscess. Scintigraphy demonstrated 
an irregular area of decreased flow and decreased blood pool in the right 
lobe medially, but a focus of increased flow and persistent increased 
blood pool activity was present in the right lobe medially, in retrospect 
shown to represent false positive prominent portal vein activity. 
70 
D. Metastatic sarcoma 
Patient 42 presented with loss of weight, right and left upper quadrant pain 
and a non-tender hepatomegaly. U ltrasonography revealed an 
inhomogeneous lesion 9 x 6 cm in diameter in the left lobe. CT demonstrate a 
low density lesion 8 x 4. 7 cm in diameter in the left lobe. Cytology of the liver 
aspirate revealed features of a metastatic sarcomatoid tumour (Appendix 20). 
Scintigraphy revealed a large area of decreased flow and decreased blood 
pool in the left lobe, but filling in of this area in the blood pool phase was 
observed by observer 111. 
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UL TRASONOGRAPHY 
Ultrasonography was performed on 40 patients (haemangioma group, n=17; 
non-haemangioma group, n=16; and indeterminate group, n=?). 
TABLE 9. Lesion number 
LESION NUMBER Patients with Patients with Patients with Patients with TOTAL 
no focal solitary two lesions ###two NUMBER 
lesions lesions lesions PATIENTS 
Haemangioma group - 10 3 4 17 
Non-haemangioma group 1 8 1 6 16 
Indeterminate group 1 4 1 1 7 
Entire group 2 22 5 11 40 
TABLE 10. Lesion location 
LESION LOCATION Patients with Patients with Patients with Patients with TOTAL 
no focal (R) lobe (L) lobe lesions in NUMBER 
lesions lesions lesions both lobes PATIENTS 
Haemangioma group - 12 - 5 17 
Non-haemangioma group 1 8 1 6 16 
Indeterminate group 1 3 2 1 7 
Entire group 2 23 3 12 40 
Lesion diameter was documented ultrasonographically in 21 patients 
(haemangioma group, n=1 O; non-haemangioma group, n=7; and 
indeterminate group, n=4). The largest lesional diameter ranged from 1.3 to 
20 cm (mean 6.6 cm) for the entire group, 2.0 to 20 cm (mean 8.1 cm) for the 
haemangioma group, 2.0 to 11 cm (mean 7.2 cm) and for the non 
haemangioma group. 
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TABLE 11. Lesion diameter 
LESION DIAMETER Range Mean NUMBER 
(cm) (cm) OF 
PATIENTS 
Haemangioma group 2.0-20 8.1 10 
Non-haemangioma 2.0-11 7.2 7 
group 
Indeterminate group 1.3-2.5 2.0 4 
Entire group 1.3-20 6.6 21 
Of the 40 patients undergoing ultrasound, 58% revealed hyperechoic lesions. 
In the haemangioma group, 76% of haemangiomas were hyperechoic, 
whereas the sonographic pattern in the non-haemangioma group was more 
variable. However, the differences between the two groups are not 
statistically significant (Fischer test, p=0, 277), implying that ultrasonography 
has little or no diagnostic value in distinguishing the lesions of these two 
groups. 
TABLE 12. Sonographic pattern 
SONOGRAPHIC Patients Patients Patients Patients Patients Patients TOTAL 
PATTERN with with with with lesion with no NO.OF 
hyperechoic hypoechoic complex isoechoic not lesion PATIENTS 
lesions lesions lesions lesions described 
Haemangioma group 13 1 3 - - - 17 
Non-haemangioma 6 1 5 1 2 1 16 
group 
Indeterminate group 5 1 - - - 1 7 
Entire group 24 3 8 1 2 2 40 
73 
COMPUTER TOMOGRAPHY 
CT imaging was performed in 32 patients. (haemangioma group, n=14; non-
haemangioma group, n=12; and indeterminate group, n=6). 
TABLE 13. Lesion number 
LESION NUMBER Patients with Patients with Patients with Patients with TOTAL 
no focal solitary two lesions ###two NO.OF 
lesions lesions lesions PATIENTS 
Haemangioma group - 10 2 2 14 
Non-haemangioma group - 7 1 4 12 
Indeterminate group 4 1 1 - 6 
Entire group 4 18 4 6 32 
TABLE 14. Lesion location 
LESION LOCATION Patients with Patients with Patients with Patients with TOTAL 
no focal (R) lobe (L) lobe lesions in NO.OF 
lesions lesions lesions both lobes PATIENTS 
Haemangioma group - 10 - 4 14 
Non-haemangioma group - 5 1 6 12 
Indeterminate group 4 1 1 - 6 
Entire group 4 16 2 10 32 
Dynamic (single level large bolus contrast injection) CT was performed in 18 
patients, and the results are presented in Table 15. Of the 14 patients from 
the haemangioma group, 8 revealed a contrast pattern compatible with 
cavernous haemangioma, 5 a contrast pattern characteristic of cavernous 
haemangioma, while one revealed a contrast pattern not typical of cavernous 
haemangioma. All 3 patients of the non-haemangioma group revealed 
contrast enhancement not typical of cavernous haemangioma. The bias 
towards the haemangioma group in Table 15 reflects the referral pattern to 
dynamic CT preferentially of patients with a high suspicion of HCH for 
confirmation of the diagnosis. The non-haemangioma group is too small to be 
significant. 
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TABLE 15. Dynamic CT contrast enhancement pattern 
DYNAMIC CT PATTERN Patients with Patients with Patients with TOTAL 
lesions lesions lesions not NO.OF 
compatible characteristic typical of HCH PATIENTS 
with HCH of HCH 
Haemangioma group 8 5 1 14 
Non-haemangioma group - - 3 3 
Indeterminate group - - 1 1 
Entire group 8 5 5 18 
The CT lesion density was documented in 28 patients and is presented in 
Table 16. In all but one patient, a low density in both haemangioma and non-
haemangioma groups was present. Lesion contrast density must be 
considered as showing no specificity as a diagnostic criterion. 
TABLE 16. Lesion contrast density 
CONTRAST DENSITY Patients with Patients with Patients with TOTAL 
low density mixed density high density NO.OF 
lesions lesions lesions PATIENTS 
Haemangioma group 14 - 14 
Non-haemangioma group 11 1 - 12 
Indeterminate group 1 - 1 2 
Entire group 26 1 1 28 
ANGIOGRAPHY 
Angiography was performed in 6 patients, revealing features compatible with 
haemangioma in one patient, focal nodular hyperplasia in one patient, 
neovascularity in 2 patients (final diagnosis hepatocellular carcinoma and 
probable hepatocellular carcinoma), hypervascularity in one patient 
(hepatocellular carcinoma) and conventional hepatic arterial anatomy in one 




It has been widely advocated in the literature that 99mTc erythrocyte blood pool 
scintigraphy is highly sensitive and specific for hepatic cavernous 
haemangiomas. The specificity and positive predictive value reported in the 
literature for planar and SPECT blood pool scintigraphy are 100% (Engel et 
al., 1983; Brunetti et al., 1988; Krause et al., 1993; lntenzo et al., 1988; 
Farlow et al., 1990; Tumeh et al., 1987; Kudo et al., 1989; Ziessman et al., 
1991 ). Some investigators recommend that a positive scan is sufficient to 
make the diagnosis and that further investigations can therefore be 
terminated once a positive result has been obtained (Engel et al. 1983; 
Krause et al. 1993; Moinuddin et al. 1985). 
In the investigation of HCH, the specificity of the test used in diagnosis is of 
greater importance than sensitivity. A false positive diagnosis of HCH as a 
benign lesion which usually does not require further treatment, may result in 
further investigation and management being stopped, whereas a false 
negative test for HCH will lead to further investigation, if clinically indicated. 
However, with regard to specificity, all studies to date have been flawed 
because insufficient non-haemangiomatous hepatic mass lesions have been 
studied. Bayesian analysis (Patrick, 1979) clearly shows that the specificity of 
a test is dependant on the pre-test probability of the lesion being present and 
that the probability of a false positive result is directly proportional to the 
number of non-haemangiomatous cases studied, i.e. if only cases of hepatic 
cavernous haemangiomas are studied, no false positives will be found. The 
probability of a false positive test increases with the number of non-HCH 
patients studied. It is important to avoid introducing bias by basing the 
diagnosis of HCH exclusively on a positive scintigraphic test, as occurred in 
some of the studies of the accuracy of scintigraphy in HCH. In the studies 
quoting a specificity of 100% (Engel et al., 1983; Brunetti et al., 1988; Krause 
et al., 1993; lntenzo et al., 1988; Farlow et al., 1990; Tumeh et al., 1987; 
Kudo et al., 1989; Ziessman et al., 1991), the number of haemangiomas 
detected ranged between 11 and 108 (mean 36) and the number of patients 
between 9 and 77 (mean 26.5) respectively. Proportionately fewer non-HCH 
lesions were studied, with a range of 5 to 46 (mean 18.6), in 5 to 29 patients 
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(mean 14) respectively. The study with the largest non-haemangiomatous 
lesion group was that of Kudo et al. (1989) - 29 patients with a total of 46 
hepatocellular carcinomas, as opposed to 77 patients with a total of 108 
haemangiomas. The small numbers of control patients relative to the number 
of patients with hepatic cavernous haemangioma, has resulted in a bias 
towards indicating high specificity of erythrocyte blood pool scintigraphy. 
Furthermore, the studies by Engel et. al (1983), Ziessman et. al (1991 ), 
Brunetti et. al (1988), it is not clear that patients in whom a diagnosis of HCH 
was made by scintigraphy, had this diagnosis confirmed by other means. It 
thus remains unclear from these studies whether patients with non-HCH 
lesions were included in the HCH group. This would also give a falsely high 
specificity for the test. 
Our study confirms the high sensitivity of the 99mTc labelled erythrocyte blood 
pool scintigraphy in the detection of hepatic cavernous haemangiomas, as 
quoted in the literature, by obtaining a high sensitivity (1.000/0.944), high 
negative predictive value (1.000/0.923) and low false negative ratio 
(0. 000/0. 056). 
With regard to specificity and positive predictive value, the results of this 
study stand in marked contrast to the results widely published in the 
literature. The low specificity (0.632), low positive predictive value 
(0. 720/0. 708) and the high false positive ratio (0.368) must also be seen in 
the context of a 48% disease prevalence, reflecting the matched number of 
patients with haemangiomatous (n=18) and non-haemangiomatous (n=19) 
lesions in the patient population studied. The finding of 7 false positive 
diagnoses of hepatic cavernous haemangioma in 37 patients (19%), clearly 
indicates that 99mTc erythrocyte blood pool scintigraphy is not sufficiently 
specific to distinguish the mostly innocuous cavernous haemangioma from 
malignant mass lesions of the liver. As hepatocellular carcinoma is common 
in the geographical area where the investigation was performed, but relatively 
rare in most other places, the series has probably been slanted towards 
hepatocellular carcinoma. This factor is however a constant feature in this 
area, posing an obvious diagnostic problem. 
This study was designed to minimise observer bias. To this end two 
independent observers, experienced in interpretation of 99mTc blood pool 
scintigraphy, interpreted the scintigrams without prior knowledge of clinical or 
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patient data. In addition, every effort was made to use non-scintigraphic data 
to clarify the nature of the lesion. Therefore the diagnosis of the lesion was 
based on clinical, biochemical, ultrasound, CT, MRI, cytological and 
histological basis in the majority of cases. The scintigraphic data was not 
used in the diagnosis of the hepatic mass lesions. Of particular importance is 
the fact that 5 of the 7 false positive cases who had characteristic 
scintigraphic features of cavernous haemangiomas, had histological or 
cytological confirmation of the diagnosis. There can be no doubt about the 
malignant nature of the disease in these patients. One of the patients with 
false positive scintigraphy (patient 18) had an alpha fetoprotein level of > 
1000 ng/ml, which was considered diagnostic and which was followed by 
rapid clinical deterioration, thereby supporting the clinical diagnosis of HCC. 
One of the patients with false positive scintigraphy (patient 3), in whom 
histology of transbronchial biopsy material demonstrated bronchial carcinoma 
but cytology of the liver aspirate revealed no malignant cells, had a diagnosis 
of bronchial carcinoma with probable hepatic metastases established on the 
basis of the clinical data and ultrasonographic appearance. 
It is possible that some patients who were diagnosed as having cavernous 
haemangioma by clinical and other criteria with confirmation on scintigraphy, 
may indeed also have been false positive and that the lesions may not have 
been cavernous haemangiomas. Therefore, this study indicates that the 
maximum specificity is 0.632. We cannot exclude that the specificity is in fact 
lower than this, as histological confirmation was obtained in only 3 patients 
diagnosed as having HCH, and in one patient the biopsy material revealed 
features compatible with lymphangioma. 
Statistically, the results of observers I and 11 are near identical (Fischer test, 
p=1.000; Mantel-Haenzel chi-square test, p=0.861 ), and the correlation was 
high ( contingency coefficient, 0.117). Although the statistical difference 
between the results of observers I and Ill, and between II and Ill were not 
significant (Fischer test, p=0.084 and 0.267; Mantel-Haenzel chi-square test, 
p=0.175 and 0.233), the correlation was poorer between both sets of results 
(contingency coefficient, 0.288 and 0.240). The results of observer Ill, 
consistently at variance with the results of both observer I and II, with a lower 
false positive and a higher false negative ratio ( 4 of the 5 false negative 
diagnoses out of 3 observers arising from observer Ill) may reflect the 
difficulties incumbent in the interpretation of erythrocyte blood pool images 
with limited experience of the method. 
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All the haemangiomas in the current study revealed the characteristic 
scintigraphic pattern of increased activity in the late blood pool phase, with or 
without progressive increase in activity intensity. The rarity of the peripheral-
centripetal filling, as reported in the literature, was confirmed with the finding 
of only one large haemangioma demonstrating this phenomenon. Only 2 (of 
25) lesions demonstrated isolated or pure decreased activity in the dynamic 
perfusion phase. This is in marked contrast to the frequency with which this 
pattern is described in the literature. Indeed, 5 haemangiomas had increased 
activity in the dynamic perfusion phase, which is generally considered to be 
rare (Larcos et al. 1989), and 4 haemangiomas demonstrated a mixed pattern 
in the perfusion phase, with small areas of increased activity, either 
contained within or situated adjacent to and contiguous with, a large(r) area 
of decreased activity. This atypical pattern has previously been described by 
Front et al. (1984) and Brodsky et al. (1987). The relative frequency of 
increased and paucity of decreased activity found in the dynamic phase in 
this study, is at variance with the findings in the literature. The 
pathophysiology of this finding is uncertain, but may be a reflection of rapid 
ingress (and egress) of radiolabelled blood, permitted by the presence of 
larger less-tortuous cavernous spaces or the presence of arteriovenous 
fistulae. However, the rapid ingress/egress required for visualization of 
increased perfusion in the dynamic phase is incongruent with the 
pathophysiological requirement of delayed egress necessary for unchanging 
or increasing intensity in the late blood pool phase. The reversing vascular 
pattern described by Hardoff et al. (1989) suggesting a double vascular 
arrangement, does not explain persistence of increased activity within an 
entire lesion or part thereof, from perfusion to late blood pool phases. This is 
an area requiring further scintigraphic and histologic correlative study, to 
define the pathophysiology and the underlying histological basis. 
The atypical appearance haemangioma, although described rarely in the 
literature, was seen in isolation in 5 haemangiomas, and contiguous with or 
contained within 4 haemangiomas also revealing typical reduced perfusion, in 
our study. It is important that this entity, more common than previously 
assumed, be seen in the light of the eight lesions/foci (corresponding to five 
or six hepatocellular carcinomas) in four patients, demonstrating similar 
increased activity in the dynamic perfusion phase and late blood pool phase. 
While the increased late blood pool phase activity is the characteristic pattern 
of haemangiomas (here false positive}, the increased perfusion seen in these 
lesions, well described in HCC, was taken to represent the atypical 
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scintigraphic appearance of HCH. In each of two of these patients, three foci 
were closely adjacent, probably representing multiple areas of increased 
vascularity and pooling in one neoplasm, rather than distinct or separate 
neoplasms. In two of the four patients, the lesions revealed an increase in 
lesional activity intensity between early and late blood pool phases, while in 
the other two patients the intensity remained constant. When increased 
perfusion is present in a lesion, the observation of clearly progressive 
accumulation of activity over time from the perfusion to the late blood pool 
phase, may help distinguish between an atypical haemangioma and a 
hepatocellular carcinoma or vascular metastasis (Larcos et al., 1989; Drane, 
1991 ). However, the increasing lesional activity intensity seen in 2 of the four 
patients with false positive HCC between early and late blood pool phases, 
suggests that even this pattern must be interpreted with caution, especially in 
the presence of increased perfusion. Quantitative analysis of early and late 
blood pool phase activity intensity may improve accuracy, but requires further 
validation (Moinuddin et al., 1985). This pattern, of atypical increased 
perfusion but characteristic late pooling, may therefore suggest the presence 
of a malignant hepatic mass lesion rather than an atypical haemangioma. 
This should prompt further investigation. The additional scintigraphic 
demonstration of inhomogeneous activity distribution in the adjacent 
parenchyma, as found in all five patients with hepatocellular carcinoma, may 
be a clue to the presence of a malignancy. The distinction of normal versus 
abnormal parenchymal vascularity is complicated by the fact that the adjacent 
parenchyma may be abnormal itself, making it difficult to use as a reference. 
The finding of increased perfusion and pooling in relation to adjacent 
(tumourous) parenchyma on blood pool scintigraphy, could be due to normal 
vascularity in remaining normal parenchyma appearing abnormal due to the 
decreased reference parenchymal activity. This may contribute to the 
generation of false positive blood pool scintigraphy. 
The remaining false positive three hepatocellular carcinomas and four 
metastatic lesions/foci lesions with normal perfusion, seen as separate and 
discrete lesions, presented a scintigraphic pattern characteristically 
associated with hepatic cavernous haemangioma. Lesional activity intensity 
remained constant except in one patient with two metastatic lesions, where 
activity intensity increased between early and late blood pool phases. The 
presence of an early arterial activity blush, as seen in one of the two patients 
with false positive metastases, may suggest a malignant vascular neoplasm, 
despite characteristic features of haemangioma. 
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While planar hepatic blood pool scintigraphy is shown to be a sensitive 
technique for the evaluation of hepatic haemangioma (Brunetti et al., 1988; 
Farlow et al., 1990; Front et al., 1981; Rabinowitz et al., 1984), the SPECT 
technique may be more accurate than planar scintigraphy where 
haemangiomas are extensively fibrosed, and little pooling of labelled 
erythrocytes occurs (Rabinowitz et al., 1984), and in detecting small, deeply 
situated cavernous haemangiomas (Langsteger et al., 1989; Tumeh et al., 
1987; lntenzo et al., 1988; Brodsky et al., 1987; Drane, 1991; Rubin and 
Lichtenstein, 1993), and/or where small haemangiomas are obscured by 
adjacent normal vascular structures (Brunetti et al., 1988). 
In this study, comparison of SPECT versus planar imaging demonstrated no 
statistical difference in the detection of hot or cold foci, although SPECT 
provided better clarity and allowed more precise localization of lesions. In the 
non-haemangioma group, three small foci were only seen on SPECT, 
suggesting that SPECT has a greater sensitivity but decreases specificity in 
the investigation of HCH. 
Scintigraphically, haemangiomas were found to be more frequently solitary 
and located in the right lobe. A similar tendency was however found with the 
non-haemangiomatous lesions. Thus, no differences were found in the 
number or location of lesions in the haemangioma and non-haemangioma 
groups. 
In summary, the efficacy of 99mTc erythrocyte blood pool scintigraphy in the 
investigation of hepatic mass lesions, as a first or second line investigation to 
distinguish cavernous haemangioma from hepatocellular carcinoma and liver 
metastases, is based upon the apparently high specificity and positive 
predictive value of this investigation for cavernous haemangioma, reported in 
the literature. While the order in which investigations for hepatic mass lesions 
are performed are still being debated, the necessity for confirmation of a 
scintigraphic diagnosis of hepatic cavernous haemangioma by other imaging 
modalities (to exclude a potentially catastrophic false positive diagnosis), 
should be reconsidered in the light of the findings of the current study. In 
contrast to several authors who advocate the termination of investigations 
upon the finding of scintigraphic features characteristic for haemangioma 
(Engel et al., 1983; Krause et al., 1993; Moinuddin et al., 1985), our study has 
shown that scintigraphy is non-specific, and that this recommendation may be 
dangerous. When the classical perfusion blood pool mismatch, with 
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decreased activity in the dynamic phase (decreased perfusion) and increased 
or increasing activity in the late blood pool phase, considered pathognomonic 
for HCH, is found, the diagnosis of HCH is relatively certain. This pattern was 
however found in isolation in only 2 and in combination with atypical 
increased perfusion in 4 of 25 haemangiomas in this study, and should 
therefore be considered the exception rather than the rule. In the absence of 
decreased perfusion, the presence of lesion activity increased in the late 
blood pool phase alone, or lesion activity which has increased or remained 
constant relative to the adjacent hepatic parenchyma from the dynamic to the 
late blood pool phase, are sensitive but non-specific criteria for HCH. These 




It has been widely accepted in the literature that 99mTc erythrocyte blood pool 
scintigraphy is a sensitive and specific tool for diagnosing cavernous 
haemangiomas of the liver and that this investigation distinguishes these 
benign lesions from hepatic malignancy. Previous studies have been based 
on flawed methodology. This study has clearly demonstrated that 99mTc 
erythrocyte blood pool scintigraphy yields a false positive rate of 36% in 
patients with hepatocellular carcinoma and hepatic metastases. Observer 
bias was reduced by the observers examining these studies in a blinded 
fashion and the correlation between two independent observers was 
excellent. The high false positive rate for scintigraphy in patients with 
hepatocellular carcinoma and hepatic metastases indicates that 00mTc 
erythrocyte blood pool scintigraphy is probably less specific for the diagnosis 
of hepatic cavernous haemangioma than expected, and that a major 
diagnostic ambiguity exists particularly in the case of hepatocellular 
carcinoma, especially in an area where this carcinoma is common. It is 
therefore essential for patients with positive scintigraphic studies to have 
confirmatory studies done if any doubt exists on clinical, biochemical or other 
radiological examination regarding the diagnosis, as incorrect diagnoses 
could have severe consequences for these patients. The exception would be 
patients with lesions demonstrating the classical perfusion blood pool 
mismatch, with absent or only partial perfusion, considered diagnostic for 
HCH. Lesions demonstrating atypical increased perfusion, either in part or in 
their entirety, in addition to features characteristic of HCH, by contrast fall 
into a high risk category. The performance of radionuclide angiography 
(dynamic perfusion phase) is therefore essential to maximise the specificity of 
the method. While the performance of SPECT is documented to improve the 
sensitivity, the risk of increasing the number of false positive lesions detected 
must be taken into consideration. 
Finally, while the role of 99mTc labelled red cell blood pool scintigraphy in the 
diagnosis of hepatic mass lesions needs to be re-evaluated, improvement of 
diagnostic accuracy would be provided by the additional performance of 
dynamic CT and/or MRI, or at best, implementation of multimodality imaging 
with image fusion. 
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APPENDIX 1 
Early History of Hepatic Cavernous Haemangioma 
STUDY DESCRIPTION / EMPHASIS 
Frerichs (1861) First description of HCH in the medical literature. 
Virchow (1863) Described a HCH 4 cm in diameter and proposed hypotheses of 
pathogenesis. 
Payne (1869) Case report of haemangiomatous liver weighing 2700 gm in association with 
haemangiomas of adrenal capsules, uterus and ovaries. 
Langhans (1879) Case report of associated liver and spleen haemangiomas. 
Birch-Hirschfeld Reported a case of large HCH in which the abdomen resembled that of a 
(1895) pregnant woman. 
Keen (1897) Reported surgical pedicle formation and elastic ligature of a HCH, 
exteriorization and extra-abdominal excision after six days. 
Schmieden (1900) Described gross and microscopic features of 32 incidental autopsy findings of 
HCH asymptomatic during life. 
Langer (1901) Reported resection of a HCH measuring 21 x 21 x 11 cm and weighing 5000 
gm. 
Fillipini (1901) Described a HCH the size of a human head. 
Mantle (1903) Reported resection of a HCH measuring 30 x 16 x 4 cm and involving 
virtually the entire right lobe. 
Von Genersich Described a HCH as large as a child's head. 
(1908) 
Chiari (1909) Described a HCH as large as a man's head. 
Roggenbau (1910) Described a HCH measuring 22 x 9 x 33 cm. 
M'Weeney (1912) Described a HCH measuring 25 x 25 x 10 cm in a liver weighing 5100 gm. 
Maccallum (1917) Described a large pedunculated HCH measuring 24 cm in diameter. 
Major and Black Described a haemangiomatous liver weighing 18160 gm and discussed 
(1918) pathogenesis of HCH. 
Rubin (1918) Reported resection of a large pedunculated HCH measuring 61 x 41 x 10 cm, 
weighing 2155 gm and causing obstetric difficulty. 
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APPENDIX 1 (continued) 
Early History of Hepatic Cavernous Haemangioma 
STUDY DESCRIPTION / EMPHASIS 
Peck (1921) Reported resection of a HCH measuring 26 x 20 x 9 cm, weighing 1700 gm. 
Tokushige (1940) Reported an autopsy case with an HCH twice the size of a man's head and 
weighing 2800 gm. 
Shumacker and Presented analysis of 67 operative cases of HCH, resection performed in 56. 
Baltimore (1942) 
Wilson and Tyson Reported 3 resections of HCH and found 84 operative cases of HCH in the 
(1952) literature. 
Henson et al. (1956b) Reported on 35 resections of HCH at the Mayo Clinic from 1907 to 1954. 
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APPENDIX 2 
Pathogenesis of Hepatic Cavernous Haemangioma - Early Hypotheses 
AUTHOR HYPOTHESIS 
Virchow (1863) Pathogenesis a process of increased liver connective tissue, followed by 
disappearance of organ secretory paths. 
Dilatation of connective tissue vessels with thickening of walls and fusion with 
surrounding connective tissue. 
Destruction of liver tissue keeps pace with growing angioma and no liver 
volume increase occurs. 
Rindfleisch (1886) Proposed a hypothesis of connective tissue origin in agreement with that of 
Burckhard (1894) Virchow and considered as important an accompanying cavernous 
metamorphosis of blood vessels. 
Beneke (1890) Considered biliary obstruction with biliary capillary (ductular) dilatation as the 
origin of HCH. 
Scheffen (1897) Suggested passive hepatic venous congestion with cavernous dilatation of 
blood vessels over time to be the pathogenetic mechanism. 
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APPEND1X3 
Pathogenesis of Hepatic Cavernous Haemangioma -
Hypothesis of Hamartomatous Origin 
AUTHOR HYPOTHESIS 
Schmieden (1900) Rejected many earlier hypotheses and concluded that: 
1. Liver cavernoma does not arise from primary connective tissue or vascular 
tumourous growth and that vascular obstruction, primary liver tissue atrophy, 
bile obstruction or haemorrhage cannot produce liver cavernoma. 
2. Pathogenesis is one of local tissue malformation during liver anlage 
development, with the final form being attained through regressive changes. 
3. Liver cavernoma is to be considered different from cavernous angiomas of 
other organs (considered to be true angiomas). 
Mantle (1903) Proposed origin of a large liver cavernous haemangioma examined at 
autopsy to be from dilatation of pre-existing vessels rather than new-vessel 
formation, shown by the presence of hepatic cells and bile ducts throughout 
the lesion and by dilatation of vessels in the uninvolved lobe. 
Borst (1911) Proposed embryonal maldevelopment of liver tissue without growth of new 
blood vessels as the origin of HCH. 
Ochsner and Halpert Vascular hamartoma, not angioma. Possesses no growth potential and 
(1958) undergoes retrogressive changes (thrombosis, organization, hyaline change) 
when there is interference with the blood circulation. 
Feldman (1958) Developmental abnormality, based on the frequent (19%) association of cysts 
with liver haemangiomas. 
Kojimahara (1986) Hamartoma, based on the ultrastructural demonstration of a basement 
membrane beneath the lining endothelium. 
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APPEND1X4 
Pathogenesis of Hepatic Cavernous Haemangioma -
Hypothesis intermediate between Hamartomatous and Angiomatous Origin 
AUTHOR HYPOTHESIS 
Ribbert (1898) Neoplasms caused by aberrant growth of sequestered vascular mesoderm. 
Borst (1911) Considered HCH to be hamartomatous but found evidence of genuine (rare) 
cavernous angioblastomata of the liver (growth in the form of endothelial 
sprouts and tubes). 




Pathogenesis of Hepatic Cavernous Haemangioma -
Hypothesis of Angiomatous Origin 
AUTHOR HYPOTHESIS 
Moore (1944) Speculated on origin as a neoplasm developing in areas of focal hepatic 
tissue necrosis with subsequent regeneration. 
O'Donoghue and Proposed origin as a neoplasm of blood vessels with independent vascular 
Nicosia (1950) growth, new vessels originating from budding of atypical angioblasts. 
Boyd (1970) Speculated that the neoplasm may consist of distinct new blood vessels and 
should be differentiated thus from telangiectatic dilatation of pre-existing 
vessels. 
Robbins (1974) Speculated on a spontaneous origin as a true neoplasm in children or adults. 
Conter and Longmire Emphasised the hypothesis of new cellular tissue origin by growth rather than 
(1988) ectasia of pre-existing vessels, based on recurrence of HCH in 4 patients 
following ablative treatment (radiotherapy in 2 and resection in 2). 
111 
APPEND1X6 
The Aetiological Role of Oral Contraceptive Steroids (OCS) 
and Exogenous Oestrogens in Hepatic Cavernous Haemangioma 
AUTHOR AETIOLOGICAL RELATIONSHIP 
Nissen et al. (1976) Reported benign liver neoplasia in 67 patients receiving OCS - FNH 23 
(34%), LCA 27 (40%), hamartoma 11 (16%). 
O'Sullivan and Described three cases of liver hamartomas in females who had received OCS 
Wilding (1974) for long periods of time. 
Tait et al. (1992) In a 10 year review of patients with liver haemangioma, found that in 25 
women, 1 O had a history of OCS use and 2 a history of progesterone use. 
All four patients having resection of increasingly symptomatic HCH had at 
some time used OCS. Symptoms developed in 2 patients while using OCS 
and cessation of OCS use did not reduce their symptoms or slow symptom 
progression. 
One male patient had received oestrogenic medication for treatment of 
prostatic carcinoma. 
Sinanan and Eight of 12 patients with diagnosed liver haemangioma reported prior or 
Marchioro (1989) concomitant oestrogen replacement after oophorectomy (6 patients) or OCS 
(2 patients). 
Morley et al. (1974) Reported the rapid growth of a liver haemangioma in a patient receiving 
exogenous oestrogens. 
Conter and Longmire Reported extensive recurrence of liver haemangioma after ablative therapy in 
(1988) four patients, three of which were women receiving oral oestrogen therapy 
prior to their original surgery, and who continued with oestrogen replacement 
until their recurrence was diagnosed. 
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APPENDIX 7 
The Aetiological Role of Pregnancy in Hepatic Cavernous 
Haemangioma 
STUDY AETIOLOGICAL RELATIONSHIP 
Rubin (1918) Rapid enlargement of liver haemangioma in 33 year old woman in her 
10th pregnancy (13 children borne of 9 pregnancies, 8 of twin 
pregnancies), requiring resection of a pedunculated HCH measuring 61 x 
41 x 10 cm and weighing 2155 gm. 
Nichols et al. (1989) Documented growth of a liver haemangioma in a patient during three 
pregnancies prior to referral for resection of a symptomatic 23 cm 
diameter lesion. 
White (1983) Sudden increase in size of a previously diagnosed liver haemangioma in a 
patient during the last trimester of pregnancy, symptoms necessitating 
resection of a 6000 gm lesion 1 month postpartum. 
Creasy et al. (1985) Enlargement of liver haemangioma in a patient from 4 cm in early 
pregnancy to 6 cm before delivery. 
Schwartz and Husser Unequivocal rapid growth of a liver haemangioma in a patient in her first 
(1987) trimester of pregnancy, although the patient's first pregnancy was 
unassociated with growth of the lesion. 
Sewell and Weiss Spontaneous rupture of a 1 O cm liver haemangioma in a 21 year old 
(1961) woman in the fourth month of pregnancy. 
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APPEND1X8 
Solitary vs. Multiple Hepatic Cavernous Haemangioma 
STUDY PATIENTS SOLITARY MULTIPLE COMMENTS 
WITH HCH (%) (%) 
Schwartz and Husser 28 93 7 Retrospective skewed 
(1987) clinicopathologic series. 
Selection bias - patients with a 
previous diagnosis of HCH 
referred for hepatic surgery. 
Ochsner et al. (1958) 55 91 9 Large autopsy series (n=2400). 
No selection bias. 
Feldman (1958) 96 91 9 Large autopsy series (n=1319). 
No selection bias. 
Henson et al. (1956b) 24 83 17 Group B: HCH discovered 
incidentally at surgical 
exploration for some other 
condition. 
No selection bias. 
Henson et al. (1956b) 11 82 18 Group A: HCH discovered at 
surgical exploration for 
symptomatic indeterminate 
hepatic masses. 
No selection bias. 
Trastek et al. (1983) 49 67 33 Retrospective skewed 
clinicopathologic series. 
Selection bias - only patients with 
HCH > 4 cm examined. 
Tait et al. (1992) 61 62 38 Retrospective skewed 
clinicopathologic series. 
Selection bias - only patients with 
HCH were examined. 
Schmieden (1900) 32 56 44 Selected pathological series. 
Selection bias - selected autopsy 
HCH specimens examined to 
investigate structure and 
genesis. 
All studies 356 78 22 Mean 
All studies 356 56-93 7-44 Range 
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APPENDIX 9 
Size of Hepatic Cavernous Haemangioma 
STUDY PATIENTS SIZE MEAN COMMENTS 
RANGE SIZE 
(cm) (cm) 
Tait et al. (1992) 61 1 - 16 3.5 Ten year retrospective review. 
Symptomatic HCH (n=7), 6 > 4 cm. 
HCH excised due to symptomatology 
(n=4), measured 5, 6.5, 8 and 16 cm. 
Asymptomatic HCH (n=54), 19 > 4 cm. 
Schwartz and Husser 12 3-8 4.7 Surgical series - nonoperative group. 
(1987) Pain in 1 O patients related to other 
pathology such as gallbladder disease. 
Lise et al. (1992) 51 5 - 20 8.5 Patients referred for surgical treatment. 
Symptomatic (n=22), asymptomatic 
(n=29), surgery performed in 25 patients. 
Bornman et al. (1987) 4 3 - 15 8.3 Surgical resection. 
Pain and mass (n=2), mass (n=1), 
incidental finding at laparotomy (n=1). 
Trastek et al. (1983) 49 4- 22 9 Surgical resection in 13 patients. 
Symptomatic (n=6), asymptomatic (n=4), 
incidental (n=2), haemorrhage post-biopsy 
(n=1 ). 
Andersson and 8 5 - 15 10 Surgical resection: 
Bengmark (1988) Suspected abdominal tumour or hepatic 
metastases (n=5), enlargement of known 
HCH (n=2) and spontaneous rupture of 
HCH (n=1). 
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APPENDIX 9 (continued) 
Size of Hepatic Cavernous Haemangioma 
STUDY PATIENTS SIZE MEAN COMMENTS 
RANGE SIZE 
(cm) (cm) 
Schwartz and Husser 16 4- 32 10 Surgical series - operative group 
(1987) (skewed, referral for hepatic surgery). 
Pain (n=5), pain and mass (n=4), 
mass and ITP (n=1}, mass (n=2), 
mass with rapid enlargement in pregnancy 
(n=1), preoperative diagnosis of HCC 
(n=1), preoperative diagnosis of 
metastasis (n=1), incidental (n=1). 
HCH excised due to symptomatology 
(n=9), measured 5, 6, 7 (2), 9, 10 (2), 14 
and 18 cm. 
Shumacker and 18 9- 32 12 Surgical resection. 
Baltimore (1942) 
Alper et al. (1988) 9 8- 23 13.3 Surgical resection. 
Pain (n=3}, pain and mass (n=3), mass 
(n=1}, asymptomatic incidental (n=2). 
Henson et al. (1956b) 11 4- 40 15 Group A: Surgical resection for 
symptomatic HCH. 
Adam et al. (1970) 22 6-45 17.2 Surgical resection for symptomatic HCH 
(n=18). 
Incidental finding at laparotomy for other 
conditions (n=4). 
Vishnevsky et al. 16 15 - 31 19 Surgical resection for symptomatic HCH. 
(1991) 
All studies 356 - 10.2 Mean of the mean values. 
All studies 356 0.4-45 - Range. 
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APPENDIX 10 
Giant Hepatic Cavernous Haemangioma 
STUDY SIZE WEIGHT COMMENTS 
(cm) (gm) 
Sewell and Weiss 10 - Spontaneous rupture (fatal haemorrhage). 
(1961) 
Aspray (1945) 12 x6 - Autopsy. Calcified. 
O'Donoghue and 16 X 14 - Surgical resection of symptomatic liver mass. 
Nicosia (1950) 
Shimizu et al. (1990) 18x12x8 1490 Surgical resection of symptomatic liver mass. 
Langer (1901) 21 X 21 X 11 5000 Surgical resection. 
Mccallum (1917) 24 - Autopsy. Pedunculated. 
M'Weeney (1912) 25 X 25 X 10 - Surgical resection. 
Peck (1921) 26 X 20 X 9 1700 Surgical resection for pain and abdominal 
enlargement. 
Mantle (1903) 30 X 16 X 4 - Surgical resection. 
Shumacker and 32 X 22 X 9 2500 Surgical resection. 
Baltimore (1942) 
Schwartz and Husser 32 - Surgical resection. 
(1987) Liver mass and pain. 
Roggenbau (1910) 33x22 X 9 - Autopsy. 
Adam et al. (1970) 45X 25 X 25 - Surgical resection. 
Large abdominal mass with RUQ tenderness. 
Rubin (1918) 61x41x10 2200 Surgical resection of a pedunculated HCH reaching 
down into the pelvis, presenting with rapid growth 
and accompanied by pain (in pregnancy). 




Lobar Distribution of Hepatic Cavernous Haemangioma 
STUDY PATIENTS (R) (L) (R) & (L) UNRECORDED/ COMMENTS 
LOBE LOBE LOBES OTHER 
(%) (%) (%) (%) 
Andersson and 8 7 (88) 1 (12) - - Surgical. 
Bengmark (1988) 
Schwartz and Husser 12 10(84) 1 (8) 1 (8) - Non-operative. 
(1987) 
Trastek et al. (1983) 49 34 (69) 3 (6) 12 (25) - Surgical. 
Adam et al. (1970) 22 13(59) 3 (14) 6 (27) - Surgical. 
Ochsner and Halpert 50 28 (56) 13 (26) - 9 (18) Autopsy. Solitary. 
(1958) 
Alper et al. (1988) 9 5 (56) 4 (44) - - Surgical. 
Henson et al. (1956b) 11 6 (55) 4 (36) 1 (9) - Surg. 
Symptomatic. 
Henson et al. (1956b) 24 11 (46) 7 (29) 4 (17) 2 (8) Surg. Incidental. 
Peck(1921) 21 7 (33) 11 (52) 1 (5) 2 (10) Surgical. 
Not recorded 1 
Spigelian lobe 1 
Shumacker and 56 18 (32) 30 (54) 5 (9) 3 (5) Surgical. 
Baltimore (1942) Spigelian lobe 1 
Accessory lobe 1 
Schnurrlappen 1 
Schwartz and Husser 16 4 (25) 8 (50) 3 (19) 1 (6) Operative. 
(1987) Quadrate lobe 
Bornman et al. (1987) 4 1 (25) 1 (25) 2 (50) - Surg. Small series. 
Ochsner and Halpert 5 1 (20) - 4 (80) - Autopsy. Multiple. 
(1958) 
Wilson and Tyson 3 - 2 (67) 1 (33) - Surg. Small series. 
(1952) 




Depth Distribution of Hepatic Cavernous Haemangioma 
STUDY PATIENTS SUB- DEEP NOT COMMENTS 
CAPSULAR STATED 
Ochsner and Halpert 50 29 4 17 Autopsy. 
(1958) Solitary HCH. 
Inconclusive. 
Ochsner and Halpert 5 4 - 1 Autopsy. 
(1958) Multiple HCH. 
Tait et al. (1992) 7 6 1 - Clinical. 
Symptomatic HCH. 
Giant HCH (5/7). 
Tait et al. (1992) 54 11 43 - Clinical. 
Asymptomatic HCH. 
Inversion of the common 
high subcapsular / 
parenchymal ratio. 
All studies 116 50 48 18 Inconclusive 
APPENDIX 13 
Association of Hepatic Cavernous Haemangioma with 
Cavernous Haemangioma in other Organs 
STUDY ORGANS INVOLVED 
Ullmann Liver and skin. 
Payne (1869) Liver, adrenals, ovaries and uterus. 
Langhans (1879) Liver and spleen. 
Roggenbau (191 O) Liver and scrotum. 
Von Falkowski (1914) Liver, spleen and skin. 
Major and Black (1918) Liver, skull and bilateral (cystic) adrenal glands. 





Association of Hepatic Cavernous Haemangioma with 
Focal Nodular Hyperplasia and Hepatic Adenoma 
STUDY PATIENTS PATIENTS % LIVERS COMMENTS 
WITH WITH WITH 
FNH HA HCH 
Ishak and Rabin 130 - 2.3 Autopsy. 
(1975) 
Benz and 34 - 20.6 Autopsy. 
Baggenstoss (1953) Retrospective. 
Mathieu et al. (1989) 26 - 23.1 Clinicopathologic. 
FNH diagnosed histologically after 
surgical resection. 
HCH (n=8, in six patients). 
HCH in same lobe or segment -
resected with FNH and diagnosed 
histologically (n=6); 
HCH in same lobe - not resected with 
FNH diagnosed by preoperative U/S 
















































































































































































































































































































































































































Prevalence of Hepatic Cavernous Haemangioma 
STUDY PATIENTS PATIENTS COMMENTS 
WITH HCH 
(%) 
Edmondson (1958) 50 000 175 (0.35) Autopsy series. 
O'Donoghue and 20 029 140 (0.7) Autopsy series. 
Nicosia (1950) 
Craig et al. (1989) 91 000 850 (0.9) Autopsy series. 
Adami (1910) 1 400 20 (1.4) Autopsy series. 
Gandolfi et al. (1991) 21 280 292 (1.4) Ultrasonographic series. 
Ochsner and Halpert 2 400 55 (2.3) Autopsy series. 
(1958) 
Feldman (1958) 1 319 96 (7.3) Autopsy series. 
Karhunen (1986) 95 19 (20) Prospective consecutive medicolegal autopsies. 
Sinanan and 60 12 (20) Clinical retrospective study. 
Marchioro (1989) 
HCH diagnosed in patients referred for surgery of 
neoplastic liver disease. 
lwatsuki et al. (1990) 547 114 (20.8) Prospective series of consecutive hepatic 
resections for neoplastic liver disease. 
Little et al. (1990) 64 33 (52) Prospective clinical series of incidental hepatic 
lesions referred for diagnosis and management. 
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APPENDIX 17 
Age and Sex Distribution of Hepatic Cavernous Haemangioma 
STUDY PATIENTS AGE AGE FIM COMMENTS 
RANGE MEAN RATIO 
(YRS) (YRS) 
Lise et al. (1992) 51 27-72 35 1.7:1 Selected surgical series. 
Resection of HCH > 5 cm. 
Symptomatic (n=22). 
Reading et al. (1988) 24 27-65 43.5 1.4:1 Clinical series. 
Henson et al. 11 1.2-58 43.6 10:1 Selected series. 
(1956b) Surgical exploration for 
symptomatic HCH. 
Shumacker and 67 6-76 44 4.5:1 Literature review of HCH in which 
Baltimore (1942) surgery was performed. 
lwatsuki et al. (1990) 114 21-77 46 3.2:1 Surgical resection of HCH. 
Bornman et al. 4 40-54 46.3 4F Surgical series. 
(1987) 
Vishnevsky et al. 16 25-61 48 1.7:1 Surgical resection of 
(1991) symptomatic HCH. 
Alper et al. (1988) 9 36-56 48.2 8:1 Selected surgical series. 
Treatment of symptomatic HCH 
by enucleation. 
Tait et al. (1992) 61 26-85 49 3.4:1 Selected clinical series. 
(median) Patients with HCH ref erred 
for assessment. 
Sinanan and 12 29-77 50 12F Surgical series. Evaluation for 
Marchioro (1989) surgery of neoplastic disease. 
Adam et al. (1970) 22 0.3-77 50.1 1.2:1 Selected series of HCH > 4 cm. 
Symptomatic (n=18). 
Starzl et al. (1980) 15 40-65 51.3 1.1 :1 Selected surgical series. 
Excisional treatment of HCH. 
Schwartz and Husser 28 29-80 50.4 3:1 Retrospective clinical series. 
(1987) 
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APPENDIX 17 (continued) 
Age and Sex Distribution of Hepatic Cavernous Haemangioma 
STUDY PATIENTS AGE AGE F/M COMMENTS 
RANGE MEAN RATIO 
(YRS) (YRS) 
Henson et al. (1956b) 24 34-75 53.8 3.8:1 Surgical series. HCH found 
incidentally at laparatomy 
for some other condition. 
Karhunen (1986) 19 35-69 53.9 19M Autopsy series (males only). 
Mcloughlin (1971) 12 33-80 57.6 5:1 Angiographic series. 
Symptomatic (n=2). 
Wilson and Tyson 84 22d-76 Data not F>M Literature review of HCH in 
(1952) available which surgery was performed. 
Plachta (1962) 13 67-86 Data not 12:1 Selected series of calcified 
available HCH. 
Edmondson (1958) 175 Data not 57.7 0.77:1 Autopsy series. 
available 




Spontaneous Rupture of Hepatic Cavernous Haemangioma 
STUDY COMMENTS 
Haefen (1898) Described the first case of spontaneous rupture of hepatic haemangioma, 
discovered at autopsy. 
Karp (1931) Reported the first case of ruptured hepatic haemangioma treated with hepatic 
resection. The patient died on 10th post-operative day. 
Tinker (1935) Reported the first successful resection of a ruptured hepatic haemangioma. 
Shumacker and Reported rupture having occurred in only 3 of 67 reviewed patients (4.5%), all 
Baltimore (1942) three of whom had had large tumours, symptomatic for more than 5 years. 
Sewell and Weiss Reviewed 12 cases of spontaneous rupture reported in the literature 
(1961) (including one case of his own), only 4 having survived (mortality 67%). 
Adam et al (1970) Reported spontaneous rupture in one (0.9%) and incisional rupture in one 
(0.9%) of 106 patients seen over a 31 year period. 
Trastek et al (1983) Found 21 cases of spontaneous rupture reported in the literature since 1898. 
Yamamoto et al Found 28 cases of spontaneous rupture reported in the literature, including 
(1991) one of his own. Of the 9 children, only 3 survived (mortality 67%). 
Ruptured haemangiomas ranged from 3 to 25 cm in diameter and many were 






























































































































































































































































































































































































































































































































99mTc Erythrocyte Blood Pool Scintigram Interpretation 
PATIENT OBSERVER I OBSERVER II OBSERVER Ill FINAL DIAGNOSIS 
1 + + + Cavernous haemangioma 
2 + + + Cavernous haemangioma 
3 + + - Metastatic carcinoma 
4 - - - Focal nodular hyperplasia 
5 - - - Indeterminate 
6 + + + Cavernous haemangioma 
7 + + + Cavernous haemangioma 
8 + + + Cavernous haemangioma 
9 + + + Cavernous haemangioma 
10 - - - Indeterminate 
11 + + + Indeterminate 
12 - - - Liver neoplasm (probably malignant) 
13 + + + Cavernous haemangioma 
14 - - - Indeterminate 
15 - - - Indeterminate 
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APPENDIX 20 (continued) 
99mTc Erythrocyte Blood Pool Scintigram Interpretation 
PATIENT OBSERVER I OBSERVER II OBSERVER Ill FINAL DIAGNOSIS 
16 - - - Metastatic carcinoma 
17 + + - Hepatocellular carcinoma 
18 + + - Hepatocellular carcinoma 
19 + + + Cavernous haemangioma 
20 + + + Cavernous haemangioma 
21 - - - Hepatocellular carcinoma 
22 + + - Indeterminate 
23 + + + Cavernous haemangioma 
24 - + - Indeterminate 
25 + + + Cavernous haemangioma (probable) 
26 + + - Cavernous haemangioma 
27 + + + Cavernous haemangioma (probable) 
28 + + + Hepatocellular carcinoma 
29 + + - Hepatocellular carcinoma 
30 - - - Hepatocellular carcinoma 
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APPENDIX 20 (continued) 
99mTc Erythrocyte Blood Pool Scintigram Interpretation 
PATIENT OBSERVER I OBSERVER II OBSERVER Ill FINAL DIAGNOSIS 
31 + + + Hepatocellular carcinoma 
32 - - - Low grade malignancy / FNH 
33 + + - Cavernous haemangioma (probable) 
34 - - - Metastatic spindle cell tumour 
35 - - - Metastatic adenocarcinoma (sigmoid) 
36 - + - Liver abscess (infected hydatid cyst) 
37 - - - Metastatic transitional cell carcinoma 
38 + + + Cavernous haemangioma (probable) 
39 - - - Metastatic adenocarcinoma 
(bronchus) 
40 + + - Cavernous haemangioma (probable) 
41 - + - Indeterminate 
42 - - + Metastatic sarcoma 
43 + + + Cavernous haemangioma 
44 + - - Cavernous haemangioma 
45 + - - Metastatic adenocarcinoma 
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APPENDIX 21 
99mTc Erythrocyte Blood Pool Scintigram Description 
PATIENT NO.OF SITE OF DESCRIPTION FINAL DIAGNOSIS 
LESIONS LESIONS 
1 1 (R) lobe Characteristic with a large area Cavernous haemangioma 
of typical and a small area of 
atypical appearance 
2 2 (R) lobe Characteristic and atypical (both) Cavernous haemangioma 
(L) lobe 
lateral segment 
3 1 (R) lobe Characteristic Metastatic carcinoma 
4 1 (R) lobe Increased arterial flow Focal nodular hyperplasia 
Decreased blood pool 
5 - - Normal blood flow and blood Indeterminate 
pool 
6 1 (R) lobe Characteristic Cavernous haemangioma 
7 1 (R) lobe Characteristic with a large area Cavernous haemangioma 
of typical and a small area of 
atypical appearance 
8 2 (R) lobe Characteristic (both) Cavernous haemangioma 
(L) lobe 
medial segment 
9 1 (R) lobe Characteristic and atypical Cavernous haemangioma 
10 - - Normal blood flow and blood Indeterminate 
pool 
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APPENDIX 21 (continued) 
99mTc Erythrocyte Blood Pool Scintigram Description 
PATIENT NO.OF SITE OF DESCRIPTION FINAL DIAGNOSIS 
LESIONS LESIONS 
11 2 (L) lobe Characteristic and typical Indeterminate 
medial segment 
12 - - Normal blood flow and blood Liver neoplasm 
pool (? malignant) 
13 2 (R) lobe Characteristic (both) Cavernous haemangioma 
14 - - Normal blood flow and blood Indeterminate 
pool 
15 - - Normal blood flow and blood Indeterminate 
pool 
16 1 (R) lobe Decreased blood flow Metastatic carcinoma 
(L) lobe Decreased blood pool 
medial segment 
ext. 
17 1 (R) lobe Characteristic and atypical Hepatocellular carcinoma 
(low grade) 
18 3 (?4) (R) lobe Characteristic and atypical (all) Hepatocellular carcinoma 
(L) lobe 
medial segment 
19 1(?2) (R) lobe Characteristic and typical Cavernous haemangioma 
(anterior segment) 
Characteristic and atypical 
(posterior segment) 
20 1 (R) lobe Characteristic with a large area Cavernous haemangioma 
of typical and a small area of 
atypical appearance 
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APPENDIX 21 (continued) 
99mTc Erythrocyte Blood Pool Scintigram Description 
PATIENT NO.OF SITE OF DESCRIPTION FINAL DIAGNOSIS 
LESIONS LESIONS 
21 1 (R) lobe Decreased blood flow Hepatocellular carcinoma 
(L) lobe Decreased blood pool 
medial segment 
ext. 
22 4(?5) (R) lobe Characteristic (all) Indeterminate 
23 1 (R) lobe Characteristic Cavernous haemangioma 
24 - - Normal blood flow and blood Indeterminate 
pool 
Prominent portal vein activity 
25 1 (R) lobe Characteristic Cavernous haemangioma 
Early/late blood pool mismatch (probable) 
26 1 (R) lobe Characteristic with a large area Cavernous haemangioma 
of typical and a small area of 
atypical appearance 
Early peripheral filling inferior 
half 
27 2 (R) lobe Characteristic and typical (R) Cavernous haemangioma 
(L) lobe lobe (probable) 
medial segment Characteristic and atypical 
(L) lobe medial segment 
28 3 (R) lobe Characteristic and atypical (all) Hepatocellular carcinoma 
(clustered) 
29 1 (2) (R) lobe Characteristic and atypical Hepatocellular carcinoma 
30 - - Normal blood flow and blood Hepatocellular carcinoma 
pool 
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APPENDIX 21 (continued) 
99mTc Erythrocyte Blood Pool Scintigram Description 
PATIENT NO.OF SITE OF DESCRIPTION FINAL DIAGNOSIS 
LESIONS LESIONS 
31 2 (R) lobe Characteristic (both) Hepatocellular carcinoma 
(L) lobe 
medial segment 
32 1 (R) lobe Decreased blood flow Low grade malignancy or 
(L) lobe Decreased blood pool focal nodular hyperplasia 
medial segment 
ext. 
33 2 (L) lobe Characteristic (both) Cavernous haemangioma 
medial segment (probable) 
34 2 (R) lobe Decreased blood flow Metastatic spindle cell tumour 
Decreased blood pool (? leiomyosarcoma) 
(both) 
35 1 (R) lobe Normal blood flow Metastatic adenocarcinoma 
Decreased blood pool (sigmoid colon) 
36 1 (R) lobe Decreased blood flow Liver abscess 
Decreased blood pool (infected hydatid cyst) 
37 - - Normal blood flow and blood Metastatic transitional cell 
pool carcinoma 
38 1 (R) lobe Characteristic Cavernous haemangioma 
(probable) 
39 - - Normal blood flow and blood Metastatic adenocarcinoma 
pool (bronchus) 
40 2 (R) lobe Characteristic (both) Cavernous haemangioma 
(probable) 
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APPENDIX 21 (continued) 
ssmrc Erythrocyte Blood Pool Scintigram Description 
PATIENT NO.OF SITE OF DESCRIPTION FINAL DIAGNOSIS 
LESIONS LESIONS 
41 1 (R) lobe Decreased blood flow Indeterminate 
Decreased blood pool 
42 1 (L) lobe Decreased blood flow Metastatic sarcoma 
Decreased blood pool 
43 1 (R) lobe Characteristic Cavernous haemangioma 
44 1 (R) lobe Characteristic Cavernous haemangioma 
45 3 (R) lobe Characteristic (all) Metastatic adenocarcinoma 
135 
APPENDIX 22 
99mTc Erythrocyte Blood Pool Scintigram Description - Terminology 
Characteristic Typical Atypical 
Activity increased in the Activity decreased in the Activity increased in the 
lesion relative to the adjacent lesion relative to the lesion relative to the adjacent 
hepatic parenchyma in the adjacent hepatic hepatic parenchyma in the 
late blood pool phase parenchyma in the dynamic dynamic phase 
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Metastatic liver disease 
Adenocarcinoma breast 
Adenocarcinoma sigmoid colon 
Adenocarcinoma undetermined 
Carcinoma bronchus 
Carcinoma poorly dffferentiated 
(?melanoma) 
Transitional cell carcinoma 
Sarcoma 
Spindle cell tumour 
(?leiomyosarcoma ) 
Hepatocellular carcinoma 
Focal nodular hyperplasia 
Low grade malignant neoplasm or 
focal nodular hype 
Liver neoplasm probably malignant 
(low grade) 
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